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SUMMARY  
Dry eye disease (DED) is one of the most frequently encountered ocular conditions, 
which is clinically under-recognized mainly due to a poor consensus on its diagnosis. 
It is considered as a multifactorial disease of the ocular surface, where the 
homeostasis of the tear film is disrupted. In 2017, the Tear Film Ocular Surface Dry 
Eye Workshop II proposed a global consensus in the diagnosis of DED. For the 
present thesis, three different studies were performed, in which the recommended 
diagnostic criteria was used, to provide a wider insight into DED epidemiology. 
Prevalence rates and risk factors for DED and DED subtypes were estimated among 
a single population in the UK. DED subtypes included aqueous deficient (ADDE) and 
evaporative (EDE) forms of the disease, described by measurements of tear 
meniscus height (TMH), tear evaporation, tear lipid layer thickness (LLT) and 
meibomian gland dysfunction (MGD). Moreover, a self-administered DED diagnostic 
method, assessing DED symptoms and the OptrexTM dry eye blink test, was 
proposed.  
Accordingly, this thesis has determined:  
• A prevalence of 19.0-56.3%, 6.2%, 64.2% and 11.1% for DED, ADDE, EDE, 
and both ADDE and EDE, respectively.  
• Age, employment status, medication intake, female sex, the presence of any 
health conditions/problems, poor sleep quality and prolonged outdoor activity 
as significant risk factors for DED. The last four factors were the most 
significant.  
• Age as a significant risk factor for EDE. 
• Ocular surface staining as the most commonly observed DED sign. 
• MGD as the most commonly observed EDE sign. 
• DED diagnosis by symptoms and tear film stability as the most suitable 
diagnostic method for the disease. 
• A diagnostic sensitivity of 100% and specificity of 54% of the proposed DED 
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1. CHAPTER 1: LITERATURE REVIEW 
1.1 Overview 
The chapter compiles available literature on dry eye disease. Its purpose is to 
summarise current knowledge in the disease definition, classification and 
epidemiology, and to identify research problems in the literature that justify the 
rationale of the present thesis. Dry eye definitions and classification schemes were 
extracted from substantial reports about the disease (Lemp et al., 2007; Craig et al., 
2017). Moreover, information about the disease epidemiology was taken from 
population-based cross-sectional studies that have been considered in (Stapleton et 
al., 2017). 
1.2 The lacrimal functional unit 
Dry eye disease can result from any alteration occurring in the anatomy and 
physiology of the lacrimal functional unit (LFU) (Figure 1.1) (Lemp et al., 2007). 
 


















The LFU is an integrated ocular system that compromises the cornea, conjunctiva, 
lacrimal glands, meibomian glands, eyelids, nasolacrimal draining system and the 
involved afferent and efferent nerves (cranial nerves V and VII) (Lemp et al., 2007). 
Its overall function is to maintain the integrity of the tear film (Lemp et al., 2007). 
1.3 The tear film 
The tear film is a transparent fluid that covers the eye. As such, it preserves the health 
of the ocular surface. It is traditionally described at the cornea as a tri-laminar 
structure (Wolff, 1946; Holly and Lemp, 1977), consisting of:  
 The lipid layer, which is the outermost layer of the tear film (Wolff, 1946; Holly 
and Lemp, 1977). It is composed of polar and non-polar lipids that are secreted 
primarily by the meibomian glands and, with a lesser amount, by the eyelid glands 
of Moll and Zeiss (Wolff, 1946; Holly and Lemp. 1977). The lipids are believed to 
retard tear evaporation from the ocular surface and hence to avoid ocular 
desiccation (Willcox et al., 2017). 
 The aqueous layer, which constitutes the bulk of the tear film (Wolff. 1946; Holly 
and Lemp. 1977). It contains mainly water and specific proteins and electrolytes 
that are protective and nutritive to the ocular surface (Willcox et al., 2017). The 
substances are secreted by the main lacrimal gland and the accessory lacrimal 
glands of Krause and Wolffring, with additional contributions arising from the 
conjunctival epithelial cells (Wolff, 1946; Holly and Lemp, 1977).  
 The mucin layer, which is the innermost layer of the tear film (Wolff, 1946; Holly 
and Lemp, 1977). It consists of mucins that are secreted by the conjunctival 
goblet cells and distributed in decreasing gradient from the ocular surface 




thought to prevent tear overspill by adhering the aqueous layer onto the ocular 
surface (Willcox et al., 2017). 
A new consensus defines the tear film as a mixture of the aqueous and mucin layer 
with an overlying lipid phase (Doane, 1994). However, there is a continual return to 
the traditional model due to its explanatory simplicity (Willcox et al., 2017).  
1.4 Definition of dry eye disease 
Efforts to define dry eye disease (DED) include the publication of three substantial 
reports (Lemp, 1995; Lemp et al., 2007; Craig et al., 2017). The National Eye Institute 
(NEI)/Industry Workshop on Clinical Trials in Dry Eyes was the first in defining DED 
(Lemp, 1995). Their definition was published in 1995 as follows: 
“Dry eye is a disorder of the tear film due to tear deficiency or excessive tear 
evaporation, which causes damage to the interpalpebral ocular surface and is 
associated with symptoms of discomfort (Lemp, 1995).” 
At this stage, DED was termed as a disorder of the tear film, where tear deficiency or 
excessive tear evaporation played causative roles (Lemp, 1995). The disorder was 
described as the presence of ocular signs that relate to symptoms of discomfort 
(Lemp, 1995). 
In 2007, a better understanding of the pathogenesis of DED allowed the Tear Film 
Ocular Surface Dry Eye Workshop I (TFOS DEWS I) (Lemp et al., 2007) to 
restructure the 1995 definition as follows: 
“Dry eye is a multifactorial disease of the tears and ocular surface that results in 




damage of the ocular surface. It is accompanied by increased osmolarity of the tear 
film and inflammation of the ocular surface (Lemp et al., 2007).” 
For the first time, DED was defined as a disease with a multifactorial nature, where 
an alteration of the tear film and ocular surface was characterized by several 
underlying causes (Lemp et al., 2007). Ocular discomfort, visual disturbance and tear 
film instability were considered as hallmarks of the disease (Lemp et al., 2007). In 
addition, hyperosmolarity and both ocular surface damage and inflammation were 
recognized as further DED markers (Lemp et al., 2007).  
Finally, in 2017, a last definition by the Tear Film Ocular Surface Dry Eye Workshop 
II (TFOS DEWS II) (Craig et al., 2017) described DED as follows: 
“Dry eye is a multifactorial disease of the ocular surface characterized by a loss of 
homeostasis of the tear film, and accompanied by ocular symptoms, in which tear 
film instability and hyperosmolarity, ocular surface inflammation and damage, and 
neurosensory abnormalities play etiological roles (Craig et al., 2017).” 
Again, DED was characterized by the presence of ocular symptoms and signs. The 
concept of “loss of homeostasis of the tear film” was included to be considered as the 
pathophysiological core feature of the disease (Craig et al., 2017). This would serve 
to acknowledge any changes occurring in the ocular surface and tear film, 
irrespective to which aetiological factor or combination of aetiological factors had 
initiated the disease process (Craig et al., 2017). 
1.5 Classification of dry eye disease 
DED is classified into two main etiological entities (Figure 1.2), evaporative or 




increasing disease severity, which can be easily assessed by scoring patients’ 
symptomatology (Craig et al.. 2017; Wolffsohn et al.. 2017).  
 
 
Figure 1.2 Sub-classification of DED 
DED = dry eye disease. * Sjögren syndrome is an autoimmune disease that affects the body exocrine glands. 
 
 
Aqueous deficient dry eye (ADDE) is characterized by a reduced secretion and 
volume of the aqueous component that arises from any damage, dysfunction or 
reduced innervation of the lacrimal gland and is divided into two major groupings, 
Sjögren syndrome and non-Sjögren syndrome (Lemp et al., 2007; Craig et al., 2017).  
Evaporative dry eye (EDE) is described as an excessive tear film loss via evaporation 
from the ocular surface in the presence of normal lacrimal function (Lemp et al., 2007; 
Craig et al., 2017). This alteration is explained by an unstable lipid layer due to blink 
and eyelid abnormalities, which are classified as either intrinsic (i.e. meibomian oil 




1.6 Epidemiology of dry eye disease 
One major challenge in the epidemiology of DED has been the lack of a standardized 
worldwide definition (Stapleton et al., 2017). This has led to the use of diverse 
diagnostic criteria, which, in turn, complicates the comparison and interpretation of 
epidemiologic study results about the prevalence and risk factors of the disease 
(Stapleton et al., 2017).  
The most consistent diagnostic criteria in the literature appears to be that first 
adopted by the Women’s Health Study (Stapleton et al., 2017). Other epidemiological 
studies have diagnosed DED either by the presence of its symptoms, signs or both 
symptoms and signs (Stapleton et al., 2017).  
1.6.1 Dry eye prevalence by the Women's Health Study criteria 
The diagnosis of DED by the Women’s Health Study (WHS) criteria is based on the 
presence of self-reported symptoms of ocular dryness and irritation either often or 
constantly, or a previous disease diagnosis by a physician (Uchino et al., 2008, 2011; 
Schaumberg et al., 2009; Zhang, Chen and Wu, 2012; Ahn et al., 2014; Um et al., 
2014; Na et al., 2015). 
The WHS criteria has mostly been conducted in Asian populations and has shown a 
DED prevalence of 12.5-23.7%, with females more affected than males  (Uchino et 
al., 2011; Zhang, Chen and Wu, 2012; Ahn et al., 2014) (Table 1.1). The lowest 
prevalence rate of 4.3% has been reported in American males (Schaumberg et al., 
2009).  
Studies describing DED by symptom self-report and clinical diagnosis separately 




2008; Uchino et al., 2011; Schaumberg et al., 2009; Zhang, Chen and Wu, 2012; Ahn 
et al., 2014; Um et al., 2014; Na et al., 2015). 
Table 1.1  DED prevalence by the WHS criteria* 












By symptom self-report 
Schaum- 
berg et al., 
2009 
USA 
≥ 50  
25444 ♂  
4.3[n/a] 3.0[n/a] 2.2[n/a] 




927 ♀  
958 ♂ 
23.7[n/a] 1.3[n/a] 23.1[n/a] 

















≥ 19  
6676 ♀ 
4990 ♂  
16.0[14.6-17.3] 8.0[7.3-8.7] 14.4[13.1-15.7] 





585 ♀  
2848 ♂ 









9398 ♀  
7033 ♂  











6655 ♀  
n/a 12.3[n/a] n/a 
DED = dry eye disease. WHS = Women’s Health Study. n/a = not applicable. ♀ = female. ♂ = male. CI = 
confidence interval. 
* Included population-based cross-sectional studies that have been considered in (Stapleton et al., 2017). 
1.6.2 Dry eye prevalence by symptoms 
The prevalence rates of DED diagnosed by symptoms (Table 1.2) are not as 
comparable as those diagnosed with the WHS criteria since they rely upon different 
definitions of symptomatic DED (Stapleton et al., 2017). Nevertheless, it can be 
generally ascertained that symptomatic DED is more prevalent in females than in 
males (Lu et al., 2008; Tongg et al., 2009; Viso, Rodriguez-Ares and Gude, 2009; 
Guo et al., 2010; Han et al., 2011; Hashemi et al., 2014; Malet et al., 2014; Paulsen 




Symptomatic DED has been described as either agreeing with a statement that 
defines the disease as having several symptoms (Vehof et al., 2014; Na et al., 2015), 
self-reporting to have at least one of several DED symptoms either often, sometimes, 
constantly or all of the time (Lu et al., 2008; Jie et al., 2009; Tongg et al., 2009; Viso, 
Rodriguez-Ares and Gude, 2009; Guo et al., 2010; Han et al., 2011; Paulsen et al., 
2014; Tan et al., 2015), or showing a positive result to the Ocular Surface Disease 
Index (OSDI) questionnaire (Hashemi et al., 2014; Malet et al., 2014). 
Studies defining symptomatic DED by symptom self-report were mostly conducted 
on Asian populations and showed different prevalence rates, ranging from 6.5% to 
52.4% (Lu et al., 2008; Jie et al., 2009; Tongg et al., 2009; Guo et al., 2010; Han et 
al., 2011; Tan et al., 2015). In the USA (Paulsen et al., 2014) and Spain (Viso, 
Rodriguez-Ares and Gude, 2009), the same method was used, reporting prevalence 
rates of 14.5% and 18.4%, respectively.  
DED symptoms, which have been agreed to be either normally present or present for 
the past three months, were found similarly prevalent among Korean (20.0%) (Na et 
al., 2015) and British females (20.8%) (Vehof et al., 2014). On the other hand, an 
OSDI score of ≥ 23 estimated a disease prevalence of 18.3% in Iran (Hashemi et al., 
2014) and of 39.2% in France (Malet et al., 2014). 
Table 1.2  DED prevalence by symptoms*  










By an  
OSDI ≥23 

























Table 1.2  (continued) 
 





1789 ♀  
2271 ♂ 
n/a All 14.5[n/a]C  
♀ 17.9[n/a]C  
♂ 10.5[n/a]C 
n/a 




≥ 65  
340 ♀  
317 ♂  
n/a All 30.3[n/a]D 
♀ 34.7[n/a]D 
♂ 25.6[n/a]D  
n/a 




561 ♀  
443 ♂  
n/a All 12.3[10.3-
14.4]E  












1112 ♀  
3327 ♂  
n/a 21.0[n/a]F n/a 




411 ♀  
243 ♂  
n/a All 18.4[15.4-
21.3]F  
♀ 21.8[17.9-25.8]F  
♂ 12.5[8.3-16.6]F 
n/a 





837 ♀  











1704 ♀  
1576 ♂  













♀ 52.9[49.5-56.3]F  
♂ 52.1[49.1-55.2]F  
n/a 






413 ♂  











561 ♀  
354 ♂  
n/a n/a All 39.2[n/a] 
♀ 44.7[n/a] 
♂ 30.5[n/a] 
DED = dry eye disease. n/a = not applicable. OSDI = Ocular Surface Disease Index. ♀ = female. ♂ = 
male. CI = confidence interval.  
* Included population-based cross-sectional studies that have been considered in (Stapleton et al., 
2017). 
A. Agreeing to have symptoms of dryness, foreign body sensation, itching burning or sandiness. 
B. Agreeing to have symptoms of foreign body sensation, itching, burning or sandiness not related to 
allergy and for the past three months. 
C. Self-reporting the use of artificial tears at least once per day or symptoms of dryness, grittiness or 
burning either moderately bothersome/greater or often/sometimes. 
D. Self-reporting at least one of six symptoms (dryness, grittiness/sandiness, burning, stickiness of 
eyelids, watery eyes/tearing and redness) either often or all of the time and for the past two weeks. 
E. Self-reporting at least one of five primary symptoms of the McMonnies questionnaire (soreness, 
scratchiness, dryness, grittiness and burning) either often or constantly. 
F. Self-reporting at least one of six symptoms (dryness, grittiness/sandiness, burning, redness, 




1.6.3 Dry eye prevalence by signs 
The prevalence of DED by signs (Table 1.3) vary considerably. Following clinical 
tests were used to describe DED by signs: 
 The fluorescein tear break-up time (FBUT) (Lu et al., 2008; Viso, Rodriguez-Ares 
and Gude, 2009; Guo et al., 2010; Hashemi et al., 2014; Malet et al., 2014), which 
determines the stability of the tear film. It measures the number of seconds that 
elapse between a blink and the appearance of the first tear film disruption, which 
is easily seen following instillation of sodium fluorescein into the eye. 
 The Schirmer test II (Lu et al., 2008; Viso, Rodriguez-Ares and Gude, 2009; Guo 
et al., 2010; Hashemi et al., 2014), which measures the aqueous production of 
the tear film. The test involves the insertion of a filter paper strip, after using ocular 
anaesthesia, over the one-third temporal lower eyelid margin. The length of the 
wet area (in millimeters) is read off after 5 minutes of application and gives an 
indication of the aqueous tear film volume.  
 Fluorescein and rose bengal staining (Viso, Rodriguez-Ares and Gude, 2009; 
Hashemi et al., 2014). Both sodium fluorescein and rose bengal are ophthalmic 
dyes used to visualize eventual ocular surface damage in DED. In DED 
epidemiology, sodium fluorescein has been exclusively used to evaluate corneal 
damage (Viso, Rodriguez-Ares and Gude, 2009; Hashemi et al., 2014). In 
contrast, rose bengal has been used to stain both cornea and conjunctiva (Viso, 






Table 1.3 DED prevalence by signs* 
 



















561 ♀  
354 ♂ 
All 44.9[n/a]A 
♀ 43.7[n/a]A  










837 ♀  
979 ♂  
All 37.7[35.5-39.9] 
♀ 35.1[31.9-38.4]  
♂ 39.9[36.9-43.0] 




♀ 6.1[4.5-7.7]  










All 35.3[33.1-37.5]  
♀ 38.1[34.7-41.4] 
♂ 33.1[30.2-36.0] 
All 35.3[33.1-37.5]  
♀ 38.1[34.7-41.4] 
♂ 33.1[30.2-36.0] 










411 ♀  
243 ♂ 








All 7.0[4.9-8.9]  
♀ 7.2[4.7-8.9]  
♂ 6.4[3.3-9.6]  
 
























♂ 9.9[6.5-13.3]  
All 4.9[3.4-6.5];  
♀ 6.0[3.9-8.1] 
♂ 3.5[1.5-5.5] 
DED = dry eye disease. n/a = not applicable. FBUT= fluorescein tear break-up time. ♀ = female. ♂ = 
male. CI = confidence interval. 
* Included population-based cross-sectional studies that have been considered in (Stapleton et al., 2017). 
A. A FBUT ≤ 5s was used instead. 
†. Corneal fluorescein staining was graded as 0 (no staining), 1 (mild staining with a few disseminated 
stains and limited to less than one third of the cornea), 2 (moderate staining with severity between grades 
1 and 3) and 3 (severe staining with confluence stains and occupying half or more of the cornea). 
‡. Corneal and conjunctival rose bengal staining was graded using the van Bijsterveld staining score 
system.  
 
An FBUT of ≤10s (Lu et al., 2008; Viso, Rodriguez-Ares and Gude, 2009; Guo et al., 
2010; Hashemi et al., 2014), Schirmer test II of <5mm/5min (Lu et al., 2008; Viso, 
Rodriguez-Ares and Gude, 2009; Guo et al., 2010; Hashemi et al., 2014), fluorescein 
score of ≥1 (Lu et al., 2008; Viso, Rodriguez-Ares and Gude, 2009; Guo et al., 2010; 
Hashemi et al., 2014) and rose bengal score of ≥3 (Viso, Rodriguez-Ares and Gude, 
2009; Hashemi et al., 2014) have estimated a disease prevalence of 15.6-37.7%, 
17.8-37.0%, 5.8-11.3% and 4.9-13.0%, respectively. However, when an FBUT value 




to 44.9%. The discrepancy in the disease prevalence may be explained by poor 
standardisation and invasiveness of the tests (Stapleton et al., 2017).  
1.6.4 Dry eye prevalence by symptoms and signs 
Four different population-based studies exist (Viso, Rodriguez-Ares and Gude, 2009; 
Hashemi et al., 2014; Malet et al., 2014; Vehof et al., 2014), whereby the prevalence 
of DED has been estimated by a combination of symptoms and signs (Table 1.4). 
Unfortunately, due to the heterogeneity of used disease diagnoses, direct 
comparisons of the prevalence rates are not possible (Stapleton et al., 2017).  
Table 1.4  DED prevalence by symptoms and signs* 
 








daily use of 
artificial tears 
By an OSDI ≥23 
or use of daily 
artificial tears 
By an OSDI ≥23 










self-report and at 
least one sign 
(FBUT ≤10s, 
Schirmer test II 
<5mm/5min, 
fluorescein 














561 ♀   
354 ♂ 




















411 ♀   
243 ♂ 
n/a n/a n/a All 11.0[8.6-13.3] 
♀ 11.9[8.8-15.1] 
♂ 9.0[5.3-12.6] 
DED = dry eye disease. n/a = not applicable. OSDI = Ocular Surface Disease Index. FBUT= fluorescein 
tear break-up time. ♀ = female. ♂ = male. CI = confidence interval. 
* Included population-based cross-sectional studies that have been considered in (Stapleton et al., 2017). 
†. Corneal fluorescein staining was graded as 0 (no staining), 1 (mild staining with a few disseminated 
stains and limited to less than one-third of the cornea), 2 (moderate staining with severity between grades 
1 and 3) and 3 (severe staining with confluence stains and occupying half or more of the cornea). 





1.6.5 Environmental risk factors for dry eye disease 
Logistic regression analyses have been performed in epidemiological studies 
concerned with quantifying associations between environmental conditions and DED 
(Uchino et al., 2008, 2011; Lu et al., 2008; Tongg et al., 2009; Jie et al., 2009; 
Schaumberg et al., 2009; Guo et al., 2010; Han et al., 2011; Zhang, Chen and Wu, 
2012; Ahn et al., 2014; Um et al., 2014; Vehof et al., 2014; Hashemi et al., 2014; 
Malet et al., 2014; Paulsen et al., 2014; Tan et al., 2015; Na et al., 2015). The term 
environment is broadly used to refer to any external and internal bodily states 
habitually experienced by an individual, such as demographic factors (i.e. age), 
lifestyle factors (i.e. contact lens wear), environmental factors (i.e. humidity) and 
physiological or genetic factors (i.e. health conditions) (Lemp et al., 2007). 
1.6.5.1 Assessing dry eye risk factors 
In logistic regression, the odds ratio (OR) is widely used to quantify how much likely 
an environmental condition contributes to DED (Uchino et al., 2008, 2011; Lu et al., 
2008; Tongg et al., 2009; Jie et al., 2009; Schaumberg et al., 2009; Guo et al., 2010; 
Han et al., 2011; Zhang, Chen and Wu, 2012; Ahn et al., 2014; Um et al., 2014; Vehof 
et al., 2014; Hashemi et al., 2014; Malet et al., 2014; Paulsen et al., 2014; Tan et al., 
2015; Na et al., 2015) (Table 1.5).  
Mathematically, the OR is calculated as follows: OR = odds of DED among individuals 
with the condition/ odds of DED among individuals without the condition, where “odds 
of DED” is defined as the probability of having the disease divided by the probability 





Table 1.5  DED risk factor assessment* 
 
Study  DED 
diagnosis 





























♂ Race/Ethnicity White  
African American  




































♂ Benign prostatic 
hyperplasia 





















































































 ♂ Visual terminal 





















































Table 1.5  (continued) 
 











 ♀ Visual terminal 

























 ♀ Myocardial 



































 ♂ Visual terminal 
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  ♂ Visual terminal 













      
 
 




Table 1.5  (continued) 
 












































 ♀ Visual terminal 

























 ♀ Myocardial 




































  Monthly household 
income 
Lowest quintile  
2nd-4th quintile  







  Education Elementary school 
Middle school 
















  Occupation Occupation Farming, 







Sales and related 
















































      










Table 1.5  (continued) 
 









  Obesity (kg/m2) Underweight (<18.5) 




























































 Binge alcohol user  Never drink an 
alcohol 
















































  Monthly household 
income 
Lowest quintile  






























































Table 1.5  (continued) 
 








Sales and related 

























































  Obesity (kg/m2) Underweight (<18.5) 









































  Binge alcohol user Never drink an 
alcohol 













  Sleep duration 
(hours) 
6-8  






























♂ Contact lens use No 
Soft contact lenses 







 ♀ Contact lens use No 
Soft contact lenses 










♂ Contact lens use No 
Soft contact lenses 



















Table 1.5  (continued) 
 
  ♀ Contact lens use No 
Soft contact lenses 

































































































































































































♀ Age (years)  1.01 [1.01-1.02] <0.0005 





























      
  
 




Table 1.5  (continued) 
 













































































































































♀ Age (years)  1.05 [1.03-1.06] <0.0005 



































































Table 1.5  (continued) 
 

















































































































































































































































































































































































































  Highest education 
attained 
No formal education  






















Table 1.5  (continued) 
 
  Type of housing  1-2 room public flat 
3-4 room public flat 





































  Age (years)  
 
3.29 [2.48-4.37] <0.001 






  Low education 






















































(OSDI ≥ 23) 






















  Body mass index 
(kg/m2) 
 0.98 [0.94-1.02] 0.41 


























  Best-corrected 
















































Table 1.5  (continued) 
 






























DED = dry eye disease. OR = odds ratio. n/a = not applicable. ♀ = female. ♂ = male. CI = confidence 
interval. 
*Included population-based cross-sectional studies that have been considered in (Stapleton et al., 2017).  
 
An OR of 1 is indicative of no effect relationship between the condition and the 
disease (Szumilas, 2010). ORs of <1 and >1 suggest that being exposed to the 
condition decreases and increases the occurrence of DED, respectively (Szumilas, 
2010). In other words, an OR of >1 means that the condition is a risk factor of DED 
(Szumilas, 2010). 
Importantly, similarly to DED prevalence rates, DED risk factors have been 
confounded by the disease diagnoses used and the population characteristics 
studied. A deeper description of identified DED associations is included further on 
(section 1.6.5.3.1 and section 1.6.5.3.2).  
1.6.5.2 Reporting dry eye risk factors 
The precision and statistical significance of ORs are often reported (Uchino et al., 
2008, 2011; Lu et al., 2008; Tongg et al., 2009; Jie et al., 2009; Schaumberg et al., 
2009; Guo et al., 2010; Han et al., 2011; Zhang, Chen and Wu, 2012; Ahn et al., 
2014; Um et al., 2014; Vehof et al., 2014; Hashemi et al., 2014; Malet et al., 2014; 
Paulsen et al., 2014; Tan et al., 2015; Na et al., 2015). Both characteristics become 
important to understand how confident a researcher can be when generalizing the 




1.6.5.2.1 The precision of dry eye risk factors 
Generally, the 95% confidence interval (CI) is used to determine the precision of ORs 
(Browner and Newman, 1986). A large 95% CI refers to less precise ORs, whereas 
a small 95% CI refers to more precise ORs (Szumilas, 2010).  
The upper and lower 95% CIs are calculated using the following formulas: Upper 
95% CI = e ^ [ln(OR) + 1.96 √(1/a + 1/b + 1/c + 1/d)] and Lower 95% CI = e ^ [ln(OR) 
+ 1.96 √(1/a + 1/b + 1/c + 1/d)], where “a” is the number of exposed individuals with 
DED, “b” the number of exposed individuals without DED, “c” number of unexposed 
individuals with DED and “d” the number of unexposed individuals without DED 
(Szumilas, 2010).  
Importantly, the 95% confidence interval depends on the sample size and the 
standard deviation of the study groups (Szumilas, 2010). A large sample size gives 
narrower 95% CIs and hence more precise ORs. On the other hand, where the 
dispersity is high, the 95% CIs are wider and the ORs are consequently less certain 
(Szumilas, 2010).  
1.6.5.2.2 The significance of dry eye risk factors 
Often, an OR with a 95% CI that does not include the value of zero effect (OR =1) is 
interpreted as statistically significant (Szumilas, 2010). However, interpretation alone 
is not enough and hence the p-value is used (Szumilas, 2010). 
The p-value is usually expressed as a proportion which can also easily interpreted 
as a percentage. Conventionally, an OR with a p-value less than 0.05 is considered 




size may arise in the sample by chance, so it is likely to represent a “real” association 
in the wider population (Szumilas, 2010).  
Note that the statistical significance of an OR can never be absolutely certain as the 
p-value is a measure of probability. There is always the possibility of committing 
errors, including false positives (to conclude there is a relationship, but in fact there 
is not) and false negatives (to conclude there is no relationship, when in fact there is) 
(Szumilas, 2010). 
1.6.5.3 Classifying dry eye risk factors 
Environmental risk factors for DED can be classified into modifiable and non-
modifiable (Stapleton et al., 2017). Modifiable risk factors for DED are those that can 
be controlled in order to decrease the chance of developing or worsening the disease 
(Jones et al., 2017). In contrast, non-modifiable cannot be changed, however, 
determining their presence may help in understanding a positive DED diagnosis 
(Wolffsohn et al., 2017).  
1.6.5.3.1 Non-modifiable dry eye risk factors  
1.6.5.3.1.1 Sex 
Females are often on major risk of DED symptoms and signs than males, suggesting 
that sex hormones may play an important role in the etiology of the disease (Sullivan 
et al., 2017).  
Sex hormones are synthesized by the gonads, by the adrenal glands or by 
conversion of steroid precursors in peripheral intracrine tissues (i.e skin or fat) to be 
then released into the blood circulation and regulate physiological functions of 




Main classes of sex hormones include androgens, estrogens and progesterones. The 
three steroids are present in each sex at different levels, considering androgens the 
“male sex hormones” and both estrogens and progesterones the “female sex 
hormones” (Truong et al., 2014; Sullivan et al., 2017).  
Androgens are believed to enhance the function of the meibomian glands by 
modulating the transport and synthesis of lipids, to regulate the secretion of the 
lacrimal gland and to stimulate the proliferation and immune response of corneal and 
conjunctival cells (Sullivan et al., 2017). On the other hand, estrogens and 
progesterones are thought to antagonize the actions of androgens; however, further 
studies are needed to clarify the precise mechanism of these sex hormones (Sullivan 
et al., 2017).  
1.6.5.3.1.2 Ethnicity 
The term ethnicity is used to classify any population study by their physical 
characteristics, such as skin colour, facial shape and hair type. In DED, Asians 
appear to be more affected by the disease, however, there are discrepancies in the 
literature (Stapleton et al., 2017). 
1.6.5.3.1.3 Age 
Although DED can develop at any age, aging is recognized as a significant risk factor 
of the disease (Stapleton et al., 2017). It encompasses inevitable structural and 
functional changes of the LFU, such as corneal irregularities accompanied with visual 
function degradation, atrophy of both lacrimal gland and meibomian glands, lid laxity 
or conjunctivochalasis (De Paiva, 2017).  
The underlying mechanism of aging on the eye is often explained by increasing 




changes (menopause), inflammatory systemic conditions and oxidative stress 
(Sharma and Hindman, 2014). Nevertheless, the cause of aging itself remains largely 
elusive.  
1.6.5.3.1.4 Health conditions 
Whether health conditions precede from DED or not remains uncertain (Stapleton et 
al., 2017). Health conditions that have been significantly associated with DED are 
hypertension (Ahn et al., 2014), thyroid disease (Ahn et al., 2014), 
hypercholesterolemia (Ahn et al., 2014), stress (Ahn et al., 2014), age-related 
macular degeneration (Vehof et al., 2014), asthma (Vehof et al., 2014), eczema 
(Vehof et al., 2014), any type of allergy (Vehof et al., 2014), rheumatoid arthritis 
(Vehof et al., 2014), stroke (Vehof et al., 2014), chronic wide pain syndrome (Vehof 
et al., 2014), pelvic pain (Vehof et al., 2014), depression (Vehof et al., 2014), fertility 
problems (Vehof et al., 2014). osteoarthritis (Vehof et al., 2014), migraine (Vehof et 
al., 2014), irritable bowel syndrome (Vehof et al., 2014), cataract (Jie et al., 2009; 
Guo et al., 2010), pterygium (Lu et al., 2008; Guo et al., 2010; Hashemi et al., 2014), 
anxiolytics (Malet et al., 2014) and general intake of medication (Tan et al., 2015). 
Further research is needed to clearly understand the nature of the association 
between these health conditions and DED (Stapleton et al., 2017).  
1.6.5.3.1.5 Ocular surgery 
Ocular surgery has been recognised as a probable risk factor of DED (Stapleton et 
al., 2017). The relationship between ocular surgery and the disease is explained by 
different surgical contributing factors.  
The main hypothesised cause of DED due to ocular surgery relates to a neural-based 




cataract and refractive surgery, involve the disruption of corneal nerves by incisions 
that may potentially interrupt the neural feedback loop between the ocular surface 
and lacrimal gland (Belmonte, Acosta and Gallar, 2004). Consequently, the aqueous 
tear film secretion is impaired, inducing eventual ocular surface desiccation and 
inflammation (Labetoulle et al., 2019).  
Surgical changes in the ocular surface and/or palpebral fissure may also disturb the 
blinking pattern, which, in turn, alter the tear film flow and stability (Chen et al., 2017). 
In refractive surgery, the correction of higher refractive errors implies deeper 
ablations depths and hence increases the risk of DED (Tuisku et al., 2007; Nettune 
and Pflugfelder, 2010).  
On the other hand, the use of a light microscope during surgery may be harmful to 
the ocular surface (Hwang and Kim, 2014). The continuous exposure to the strong 
light of the microscope on the ocular surface has shown to retard the incision closure 
(Ipek et al., 2018). Similarly, ocular tissue wounding may be delayed by the use of 
surgical antiseptics drops (Thomas et al., 2009) and post-surgical medications 
containing preservatives (Baudouin et al., 2010). 
1.6.5.3.1.6 Environmental conditions 
The eye is directly exposed to the outside and therefore is endangered by a multitude 
of factors occurring in an individual’s surrounding (Stapleton et al., 2017).  
At present, controlled adverse environment chambers have served to study closely 
the effect of the environment on DED (Calonge et al., 2018). For instance, variations 
in temperature, airflow velocity and relative humidity, and passive cigarette smoking 
have demonstrated to alter the tear film homeostasis (by increasing tear film 




al., 2010; Tesón et al., 2013; López-Miguel et al., 2014; Martín-Montañez et al., 
2016). 
Other studies have significantly associated high altitude (Lu et al., 2008; Guo et al., 
2010), and higher ozone levels and lower humidity levels with DED symptoms 
(Hwang et al., 2016). In addition, the chronic exposure to traffic derived air pollution 
can contribute to DED characterized by symptoms and signs of tear film instability 
(Novaes et al., 2010).   
1.6.5.3.2 Modifiable dry eye risk factors 
1.6.5.3.2.1 Visual display terminals 
DED symptoms may impact adversely an individual’s ability to perform tasks 
requiring sustained visual concentration (Miljanović et al., 2007) and may contribute 
to a lower quality of life (Tong et al., 2010). Long-term use of visual display terminals 
(VDT), especially for more than four hours daily, has been associated with DED 
(Kojima et al., 2011; Uchino and Schaumberg, 2013).  
Vision problems related to VDT use have been designated as “computer vision 
syndrome (Gowrisankaran and Sheedy, 2015). The term computer vision syndrome 
includes symptoms of eyestrain, ocular fatigue, burning sensation, irritation, redness, 
blurred vision and dryness (Gowrisankaran and Sheedy, 2015).   
DED symptoms due to VDT use has been suggested to occur due to both reduced 
blink rate and incomplete blinking (Wolkoff et al., 2005; Portello, Rosenfield and Chu, 
2013; Chu, Rosenfield and Portello, 2014; Argilés et al., 2015). Changes in blinking 




mild epithelial damage (Wolkoff et al., 2005; Portello, Rosenfield and Chu, 2013; Chu, 
Rosenfield and Portello, 2014; Argilés et al., 2015).  
Interestingly, the blink rate has been shown to decrease as font size and contrast are 
reduced (Gowrisankaran, Sheedy and Hayes, 2007) or cognitive demand of the task 
increased (Himebaugh, 2009; Jansen et al., 2010). 
1.6.5.3.2.2 Contact lens wear 
Contact lenses are optical devices made from biocompatible polymers that are 
designed to be applied onto the eye to correct vision.  
DED signs and symptoms that are exclusive to contact lens wear have extensively 
been studied in the literature as contact lens discomfort (CLD) (Nichols et al., 2013). 
CLD is described as having either intermittent or persistent adverse ocular sensations 
during lens wear that are often interpreted as ocular dryness (Nichols et al., 2013). 
Importantly, CLD has not clearly been distinguished from DED prior to contact lens 
wear and hence further research is needed in this area (Nichols et al., 2013).  
During lens wear, the tear film needs to lubricate and hydrate the contact lens for 
preserving the health of the ocular surface (Efron et al., 2013). However, the physical 
presence of the contact lens in situ disrupts normal tear film function and stability 
dividing the tears into two compartments, the post-lens and pre-lens tear film (Holly 
1981).  
Both integrity and replenishment of the post-lens and pre-lens tear film are critical for 
cushioning the effect of blinking (Efron et al., 2013). In the event of DED, contact lens 
wearers have reported low tear break-up times and ocular surface staining, 




et al., 2013). Low tear film volume has also been associated with DED during contact 
lens wear (Efron et al., 2013).   
1.6.5.3.2.3 Poor sleep quality 
The relationship between poor sleep quality and DED (Zhang, Chen and Wu, 2012; 
Ahn et al., 2014) has been scarcely studied. Poor sleep quality has been described 
either by short sleep duration (Ahn et al., 2014) or having inadequate sleep (Zhang, 
Chen and Wu, 2012). 
Sleep deprivation is thought to increase sympathetic and decrease parasympathetic 
tone (Tobaldini et al., 2017). Whereas the lacrimal gland is innervated by both 
sympathetic and parasympathetic nervous systems, the latter is most extensive 
(Belmonte et al., 2017) and hence any kind of sleep disturbance may considerably 
lessen tear secretion. 
Accordingly, a small case-control study among healthy male sleepers has shown that 
staying awake for twenty-four hours reduces tear film volume and stability, as well as 
increases tear film osmolarity, leading to ocular discomfort (Lee et al., 2014).  
Insomnia has also been related to DED by symptoms (Galor et al., 2018) and both 
symptoms and signs (Ayaki et al., 2016). The association is explained by the 
coexistence of mood disorders (Galor et al., 2018) and ocular pain (Ayaki et al., 2016) 
that possibly induces distress and exacerbates difficulties in falling asleep. 
1.6.5.3.2.4 Nutrition  
The association between certain conditions, such as vitamin A deficiency, anorexia, 
bulimia, malabsorption syndromes (usually associated to alcoholism) (Stapleton et 




homeostasis of the tear film. Hence, the involvement of nutritional and/or dietary 
components on tear composition and physiology has been studied.  
Supplementary vitamins are believed to protect the ocular surface from oxidative 
stress (Seen and Tong, 2018). For example, vitamin C has been reported to play an 
important role in corneal wound healing after refractive surgery (Kasctsuwan et al., 
1999). Multivitamin-trace supplementations, including vitamin A, vitamin B1, vitamin 
B2, vitamin B6, vitamin B9, vitamin E, vitamin C, calcium, iron, magnesium and/or 
zinc, have also shown to increase both tear film stability and volume of DED 
participants (Patel, Plaskow and Ferrier, 1993; Drouault-Holowacz et al., 2009). 
Moreover, DED participants have been benefited by a balanced intake of omega-3 
and omega-6 (Roncone, Bartlett and Eperjesi, 2010; Rosenberg and Asbell, 2010; 
Oleñik, 2014; Bhargava et al., 2015; Gatell-Tortajada, 2016).  Both essential fatty 
acids are recommended as they display anti-inflammatory properties systematically 
and have shown to retard tear film evaporation and to enhance tear film secretion 
(Roncone, Bartlett and Eperjesi, 2010; Rosenberg and Asbell, 2010; Oleñik, 2014; 
Bhargava et al., 2015; Gatell-Tortajada, 2016).  
Importantly, more research is needed to understand which dose, composition and 
length of nutritional supplementation, either of vitamins (with or without trace 
elements) or essential fatty acids, are required to effectively treat DED (Stapleton et 
al., 2017).   
1.7 Thesis rationale 
The prevalence and risk factors of DED are difficult to establish. Indeed, both have 




used for the diagnosis of the disease. Moreover, the knowledge about DED subtypes 
is limited. The goal of the present thesis is to perform research on DED; more 
specifically, to examine in isolation the impact of different diagnostic criteria on the 
disease prevalence (Chapter 3) and to evaluate the associated risk factors (Chapter 
4), to understand if DED outcomes and risk factors may be more related to aqueous-
deficient or evaporative components of the disease (Chapter 5), as well as to explore 
a cheap and feasible diagnostic method that may be useful for future population-
based studies about DED (Chapter 6). To do so, data were collected from a single 
population in the UK and great care was taken in following a well-standardized study 





2. CHAPTER 2: STUDY METHODOLOGY 
2.1 Overview 
The chapter discusses the study methodology of the present thesis. It explains the 
rationale behind the chosen tests and the strengths and limitations of each method 
used. 
2.2 Study design 
A cross-sectional study was conducted at Aston University Eye Clinic. This research 
is observational in nature as it attempts to simultaneously explore the prevalence and 
risk factors of DED. The study was approved by the ethical committee of Aston 
University and conformed to the tenets of the Declaration of Helsinki. 
2.2.1 Power calculation 
Two hundred sixty-five participants were estimated to be an appropriate sample size 
for the present study. The sample size was calculated by considering a CI of 95% 
and using the following formula: n = (((1.962)P(1-P))/d2) (Arya, Antonisamy and 
Kumar, 2012), where “n” is the sample size, “P” the expected disease prevalence 
and “d” the allowable error. As “P”, the prevalence rate for DED of 22.1% from a 
British female cohort (Prevalence: 20.8% [95% CI, 19.5-22.1]) (Vehof et al., 2014) 
was used. The rationale to set “P” at 22.1% is based on the fact that any value nearer 
to 50% leads to the largest “n”  (Figure 2.1)  and hence to more confident results 
(Arya, Antonisamy and Kumar, 2012). Moreover, because an allowable error of 0.05 
has been generally recommended when “P” takes values between 10% and 90% 





Figure 2.1 Relationship between sample size and expected prevalence 

























2.2.2 Study population 
The population about conclusions were drawn were female and male adult residents 
in Birmingham (UK), regardless of nationality. Estimates about Birmingham resident 
population for 2016 were obtained from the Birmingham City Council 
(www.birmingham.gov.uk/census) and considered together with the above power 
calculation to determine the required study participants (Table 2.1). 
Table 2.1  Required study population (stratified by age and sex) 
Age (years) 18-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 
Sex Males (n) 6 31 25 22 19 14 9 5 
Females (n) 6 31 25 22 20 14 10 7 
 
2.2.3 Recruitment 
Great efforts were made to recruit as many eligible participants as possible. 
Recruitment mainly occurred through Aston University staff email advertising, via 
advertisement within the Aston Eye Clinic and Aston Research Centre for Healthy 
Ageing (ARCHA), and through posters pinned around the campus (Figure 2.2). 
Further recruitment methods included leaflet advertising in the Birmingham City 
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2.2.4 Inclusion and exclusion criteria 
To participate in the study, participants were required to be ≥18 years-old. They 
needed to be Birmingham residents who did not leave the country one month before 
the study to ensure that environmental differences between participants were 
minimised. The highest age limit was set at 90 years as the tests required 
considerable cooperation. Eligible participants were invited via email and advised to 
not wear contact lenses or use artificial tears twenty-four hours prior to the study.  
2.2.5 Clinical assessment 
In a single clinical session lasting approximately one hour, participants were first 
asked to complete a dry eye risk factor survey and two dry eye questionnaires, 
followed by a full ocular surface and tear film examination on their preferred eye.  
 




All participants were examined in an adjacent room of the Aston University Health 
Clinics (Figure 2.3) from September 2016 to March 2018. Throughout the study, the 
room temperature and humidity were kept by 22.4 ± 2.0°C and 49.3 ± 8.2%, 
respectively. Eye examinations only occurred after a minimum of 15 minutes of 
adaptation to the room conditions. 
2.2.5.1 Diagnostic considerations 
Minimal manipulation to the ocular surface may alter tear film physiology by inducing 
reflex tearing or adding foreign bodies into the tears. Invasive methods, such as the 
use of ophthalmic dyes to improve tear film visibility, are criticised due to disrupting 
the normal tear film state (Mooi et al., 2017) and hence providing less reliable results 
(Nichols, Mitchell and Zadnik, 2004). In addition, automated methods are strongly 
recommended since they are less dependent on examiners´ clinical expertise 
(Nichols et al., 2002).  
The main instrument used for the present study was the Keratograph 5M (K5M; 
Oculus Optikgeräte GmbH, Wetzlar, Germany) (Figure 2.4), a topographer using a 
video analysis software to overcome inaccuracies made by invasive and subjective 
testing of important dry eye parameters. However, where non-invasive and objective 
methods were not possible, traditional methods were carefully adopted following 
substantial training. Finally, to minimise the impact of subsequent testing on tear film 
physiology, the involved diagnostic methods were performed in increasing order of 










2.2.5.2 Dry eye risk factor survey 
Information about the exposure of DED risk factors was obtained through a self-
administrated Dry Eye Risk Factor Survey (DERFS) ( 
Figure 2.5). The survey was developed aiming to evaluate all DED risk factors 
assessed in current cross-sectional studies (Chapter 1). It included questions about 
participants’ demographics and life factors, including: 
 Ethnicity. The term ethnicity has been used to classify populations into subgroups 
based on physical characteristics. Because Asians, including Korean, Chinese 
and Japanese populations, have been significantly associated with DED 
(Stapleton et al., 2017), an ethnicity classification including this ethnic group was 
considered. 
 Age. DED is known to increase with age (Stapleton et al., 2017). Participants’ age 
decade was recorded, as this is less intrusive than assessing their precise age. 
The approach has largely been used in DED epidemiological research 
(Schaumberg et al., 2009; Tongg et al., 2009; Uchino et al., 2011; Ahn et al., 
2014; Um et al., 2014).  
 Sex. Sex hormones may play an important role in DED (Truong et al., 2014; 
Sullivan et al., 2017) and hence participants’ sex was recorded.  
 Living zone and outdoor activity. DED has been significantly related with urban 
areas (Jie et al., 2009; Han et al., 2011; Ahn et al., 2014) and outdoor ozone air 
pollution (Hwang et al., 2016). Therefore, both factors were assessed. The living 
zone was classified into rural and urban areas (Jie et al., 2009; Han et al., 2011; 
Ahn et al., 2014). Because data collection on air pollution as in (Hwang et al., 
2016) was not possible, the exposure to outdoor air pollution was graded by 




 Education. DED has been significantly associated with higher educational level 
(Ahn et al., 2014; Malet et al., 2014), as well as office-based work (Ahn et al., 
2014). Education was categorized as elementary/primary school, 
middle/secondary school, high school/6th form, and university/higher (Ahn et al., 
2014). Work was described by participants’ daily working hours. Importantly, 
classifying work as non-office-based and office-based might have been 
intercorrelated with computer use (Ahn et al., 2014) and hence was not 
considered. 
 Smoking. Smoking has been significantly associated with DED (Lu et al., 2008; 
Ward et al., 2010). Although smoking habits have been described as generally 
smoking (Lu et al., 2008), the number of cigarettes smoked per day was asked to 
provide a more detailed analysis.  
 Drinking. The relationship between alcohol consumption and DED is controversial 
(You, Qu and Yu, 2016). The risk factor was assessed by asking participants’ 
weekly alcohol unit intake. 
 Contact lens wear. Both rigid and soft contact lenses interrupt normal tear film 
function and physiology (Efron et al., 2013; Nichols et al., 2013), contributing most 
likely to DED (Uchino et al., 2008, 2011; Zhang, Chen and Wu, 2012; Paulsen et 
al., 2014; Vehof et al., 2014; Tan et al., 2015). The risk factor was assessed by 
recording participants’ contact lens type (Uchino et al., 2008) and wear frequency 
in days per week. The contact lens wear frequency was asked to provide a more 
detailed analysis. 
 Computer use. Changes in blinking patterns due to computer use can lead to 
DED (Wolkoff et al., 2005; Portello, Rosenfield and Chu, 2013; Chu, Rosenfield 
and Portello, 2014; Argilés et al., 2015). As in (Uchino et al., 2011; Malet et al., 




 Current/past health conditions/problems, medication use and stress. DED has 
been significantly related to several systemic and mental health 
conditions/problems, as well as to the use of medication and stress (Lu et al., 
2008; Jie et al., 2009; Guo et al., 2010; Ahn et al., 2014; Hashemi et al., 2014; 
Malet et al., 2014; Vehof et al., 2014; Tan et al., 2015). Hence these factors were 
asked. Moreover, participants’ stress status was classified into least, moderate 
and extreme (Ahn et al., 2014). 
 Nutritional supplements intake. Recording of nutritional supplementation was 
considered since these are suggested as DED treatments (Jones et al., 2017) 
and may undercover a possible DED diagnosis and/or risk factor. 
 Sleep quality. Sleep deprivation has been significantly associated with DED 
(Zhang, Chen and Wu, 2012; Ahn et al., 2014). Participants’ regular sleeping 






THE DRY EYE RISK FACTOR SURVEY  
To which group do you belong?  Underline if applicable 
 
Ethnicity → White/ Asian/ Black/ Others 
    
Sex → Female/Male 
    
Age → 10s/ 20s/ 30s/ 40s/ 50s/ 60s/ 70s/ 80s 
        
Residential area → Rural/Urban 
   
Education → Elementary or primary school/ Middle or secondary school/ High school or 
6th form/ University or higher 
        
Do you … Underline and/or complete if applicable 
     
Work? No  Yes → Hours/day  
  ↓     
       
Smoke? No Yes → Cigarettes/day  
  ↓     
       
 Drink alcohol? No Yes → Units/week  
  ↓    1 unit = 1 glass of beer, 
wine or spirit 
       
Wear contact lenses? No Yes → Type  Days/week  
  ↓       
       
Use computer? No Yes → Hours/day  
  ↓     
       
Have/ have had any health 
condition/problem? 





No Yes  
  ↓     
       
Have had any eye surgery? No Yes → Describe  
  ↓     





Take any medication regularly? No Yes  
  ↓     
Take any nutritional supplement 
regularly? 





No Yes  
    
       
How … Underline and complete if applicable      
      
Much sleep do you get? →   Hours/night  
     
 Much do you spend outdoors 
on a regular leisure day? 
   
→ Hours/leisure day  
     
Stressful are your days? → Least stressful/ Moderately stressful/ Extremely stressful 
       
 





2.2.5.3 Dry eye questionnaires 
DED symptoms can be gathered either through non-scripted verbal interviews or self-
administered questionnaires (Wolffsohn et al., 2017). However, self-administered 
questionnaires are preferred given their enhanced standardization in recording the 
disease symptomatology (Wolffsohn et al., 2017).   
Currently validated symptom questionnaires with discriminative ability in DED include 
the Impact of Dry Eye on Everyday Life (IDEEL) (Guillemin et al., 2012), the  
McMonnie’s Questionnaire (MQ) (Gothwal et al., 2010), the 5-item Dry Eye 
Questionnaire (DEQ-5) (Chalmers, Begley and Caffery, 2010) and the Ocular 
Surface Disease Index (OSDI) (Schiffman et al., 2000). 
The two questionnaires chosen for the present study were the DEQ-5 and OSDI. The 
questionnaires have been found to be concurrent with each other (Galor et al., 2015) 
and are currently recommended to be used for the diagnosis of DED (Wolffsohn et 
al., 2017). Whereas the DEQ-5 is found attractive due to its short length, the OSDI is 
recommended because of its strong establishment in the field of DED clinical trials 
(Wolffsohn et al., 2017).  
Symptomatic DED was determined using a DEQ-5 cut-off score of ≥6 (Chalmers, 
Begley and Caffery, 2010) and ODSI score of ≥13 (Schiffman et al., 2000). The 
questionnaires were presented together on a single document page (Figure 2.6). 
Participants were also asked if they have had eye irritation, either rarely, sometimes, 
frequently or constantly, for the past month and a previous diagnosis of DED by a 
physician. The questions were added to further diagnose DED by the WHS criteria, 
which accounts as the most widely used previous diagnostic criteria in the 





DRY EYE QUESTIONNAIRES 
Instructions: Circle the number in the box that best represents each answer. 
       
Have you experienced any of the following during the last week: 











1. Eyes that are sensitive to light? 4 3 2 1 0  
2. Eyes that feel gritty? 4 3 2 1 0  
3. Painful or sore eyes? 4 3 2 1 0  
4. Blurred vision? 4 3 2 1 0  
5. Poor vision? 4 3 2 1 0  
 




6. Reading? 4 3 2 1 0 N/A 
7. Driving at night? 4 3 2 1 0 N/A 
8. Working with a computer or a 
bank machine (ATM)? 
4 3 2 1 0 N/A 
9. Watching TV? 4 3 2 1 0 N/A 
 
Have your eyes felt uncomfortable in any of the following situations during the last week: 
 
 
10. Windy conditions? 4 3 2 1 0 N/A 
11. Places or areas with low 
humidity (very dry)? 
4 3 2 1 0 N/A 
12. Areas that are air-
conditioned? 
4 3 2 1 0 N/A 
       
1 Questions about EYE DISCOMFORT:  
a. During a typical day in the past 
month, how often did your eyes 
feel discomfort? 
 









b. When your eyes feel 
discomfort, how intense was this 
feeling of discomfort at the end of 
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2 Questions about EYE DRYNESS: 
a. During a typical day in the past 
month, how often did your eyes 
feel dry? 
 









b. When your eyes feel 
discomfort, how intense was this 
feeling of dryness at the end of 
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3 Questions about WATERY EYES: 
a. During a typical day in the past 
month, how often did your eyes 
feel watery? 
 









4 Questions about IRRITATED EYES: 
a. During a typical day in the past 
month, how often did your eyes 
feel irritated? 
 









      
Have you had a previous clinical diagnosis of dry eye? Yes   No  
      
      
Figure 2.6  DED questionnaires used 




2.2.5.4 Tear film evaporation 
Increased tear film evaporation is thought to result from tear film instability caused by 
an impaired lipid layer (Craig and Tomlinson, 1997). In the present study, tear film 
evaporation was evaluated, although its discriminative ability in DED has not been 
determined yet (Wolffsohn et al., 2017).  
Non-DED and DED individuals have shown tear film evaporation rates of 48.85 ± 
23.47 g/m2/h and 75.78 ± 50.26 g/m2/h, respectively (Tomlinson, Doane and 
McFadyen, 2009). The tear film evaporation rates have been assessed using 
evaporimeters with open and closed chambers (Tomlinson, Doane and McFadyen, 
2009). The evaporimeters contain sensors that detect changes occurring at the 
ocular surface, either of vapour pressure or relative humidity, from which the tear film 
evaporation is inferred (Tomlinson, Doane and McFadyen, 2009).  
Measuring tear film evaporation is challenging. The tear film evaporation rate has 
shown to fluctuate highly with day time (Wojtowicz and McCulley, 2009), room 
humidity (Abusharha and Pearce, 2013) and temperature (Abusharha, Pearce and 
Fagehi, 2016). Moreover, tear film evaporation readings may be confounded by 
additional evaporation coming from the eyes’ surrounding skin (Wolffsohn et al., 
2017). 
The Delfin VapoMeter (Delfin Technologies Ltd, Kuopoi, Finland) (Figure 2.7) was 
used to assess the tear film evaporation rate. The core of the VapoMeter has a 
hygrometer sensor that monitors the increase of relative humidity, from which the tear 
film evaporation rate is deducted in units of g/m2/h. The humidity is measured within 
a swimming google piece that is enclosed by the eye during measurement. 




by the manufacturer. Three consecutive tear film evaporation readings were taken, 
and the mean was recorded.  
 
 
Figure 2.7 Tear evaporation measured with the Delfin VapoMeter 
The standard adapter (swimming google piece with an opening diameter of 11mm) of the Delfin VapoMeter 
was applied on the participants’ eye. The tear evaporation was deducted from the humidity increase measured 
by the hygrometer sensor of the adapter. Three consecutive tear film evaporation readings were taken, and 
the mean was recorded. 
2.2.5.5 Tear film osmolarity 
Higher than normal physiological solute concentration in the tear film is known as tear 
hyperosmolarity. Tear hyperosmolarity results either from excessive evaporation in 
the presence and/or absence of normal tear flow and constitutes the major trigger of 
other events leading to ocular surface damage and inflammation (Lemp et al., 2007).  
Among other clinical tests, tear film osmolarity has been demonstrated to be the best 




correlation to the disease severity (Lemp et al., 2011) and the lowest variability over 
time scales that are clinically relevant (Sullivan et al., 2012).  
Unlike non-DED individuals, DED individuals show unstable osmolarity values with 
greater intra- and interocular variability with increasing disease severity (Tomlinson et 
al., 2006; Keech, Senchyna and Jones, 2013). Several cut-off scores have been 
suggested to distinguish both groups (Bron et al., 2014). To date, a threshold of ≥308 
mOsm/l of either eye or a difference of >8mOsm/l between eyes is globally 
recommended for the diagnosis of DED (Bron et al., 2014).   
Past measurements of tear film osmolarity are based on determining one of two 
colligative properties of the tear film: the freezing point or vapour pressure (Tomlinson, 
McCann and Pearce, 2010; Gokhale, Stahl and Jalbert, 2013). Both freezing point and 
vapour pressure techniques have been criticised for requiring considerable expertise as 
well as for being invasive (causing reflex tearing during tear collection) and time-
consuming (allowing tear evaporation during tear analysis) (Tomlinson, McCann and 
Pearce, 2010; Gokhale, Stahl and Jalbert, 2013).  
In the present study, the tear film osmolarity was measured temporally from the 
inferior tear meniscus with an electic impedance-based osmometer: the TearLab 
Osmolarity System (TearLab Corporation, California, USA) (Figure 2.8). During 
measurement, the participants were asked to look up and away from the instrument. 
Readings were collected from each eye, and both osmolarity values and the 





Figure 2.8  Tear osmolarity measured with the TearLab Osmolarity System 
The osmolarity pen was gently lowered until the bottom of the tip touched the lower tear meniscus height of 
the temporal eyelid canthus. Osmolarity readings were obtained within 40 seconds of successful tear 
collection. 
 
The TearLab Osmolarity System is considered minimally invasive, as it samples low 
tear film volume (less than 20nl) without direct contact with the ocular surface 
(Tomlinson, McCann and Pearce, 2010). However, it may be limited due to the fact 
that it measures the osmolarity of the tear film within the lower tear meniscus, which 
is hypothesised to be slightly more dilute than other parts of the tear film (Bron et al., 
2002).  
2.2.5.6 Tear film volume  
Evaluating tear film volume is essential for detecting aqueous-deficient components 
of DED (Wolffsohn et al., 2017). In clinical settings, following diagnostic methods 




• The Schirmer test. The Schirmer test involves the insertion of a filter paper 
strip, after using (Schirmer test II) or not using (Schirmer test I) ocular 
anesthesia, over the one-third temporal lower eyelid margin (Schirmer, 1903). 
The length of the wet area (in millimeters) is read off after 5 minutes of 
application and gives an indication of the aqueous tear film volume (Schirmer. 
1903). A Schirmer score of ≤5 mm/5 min has been proposed to be abnormal, 
meaning the presence of aqueous tear deficiency (Bron et al., 2007). 
Nevertheless, the clinical application of the Schirmer test is disputed, as it is 
highly variable, unreliable and poorly correlated to other DED signs and 
symptoms (Senchyna and Wax, 2008).  
• The phenol red thread test. The phenol red thread (PRT) test consists of a 
phenol-red-impregnated cotton thread that is applied onto the eye, in a similar 
manner to the Schirmer test, but without needing topical anesthesia (Patel et 
al., 1998). It has been developed to overcome the disadvantages of the 
Schirmer test, however, with no success (Senchyna and Wax, 2008). The 
PRT test has found to be poorly reliable as the Schirmer test (Moore et al., 
2009), falling in disuse for more than ten years ago (Wolffsohn et al., 2017). 
• The tear meniscus height. The tear meniscus is the collection of tears at the 
intersection of the bulbar conjunctiva and the eyelid margins. Its height 
represents 75-90% of the tear film volume (Holly, 1985) and is evaluated 
central inferior (in millimeters) with en-face slit lamp observation either using 
a reflective graticule (TMH) or sodium fluorescein (FTMH).  
Among all tests, the TMH accounts the minimally invasive method to assess tear film 




of tear film homeostasis and has demonstrated good repeatability with low individual 
variability (Uchida et al., 2007).  
In the present study, TMH was assessed with the “Tear Meniscus Height” setting of 
the K5M and at magnification of 1.4x (Figure 2.9). Digital infrared-images were taken 
at the centre of the lower eyelid, with no eyelid manipulation. The TMH was centrally 
measured once, using the vertical alignment of the K5M reflective graticule as a 
reference.  
 
Figure 2.9  Lower TMH measured with the Keratograph 5M 
TMH = tear meniscus height.  
The central THM was analysed by the Tear Meniscus Height TF-Scan software of the Keratograph 5M. It was 
measured once, using the vertical alignment of the of the Keratograph 5M reflective graticule as a reference.  
 
2.2.5.7 Lipid layer thickness 
White light interferometry is a valuable technique for measuring the lipid layer 




interferometric colour fringes observed by specular reflection at the tear lipid-aqueous 
interface (Guillon, 1982; Korb et al., 1994).  
Thickening of the lipid layer has shown to cause an interferometric colour change 
from grey to red, which is typically observed when the interpalpebral aperture is 
narrowed (McDonald, 1969) and may occur by forced blinking (Korb et al., 1994).  
Recently, an automated interferometer has been introduced (Goto et al., 2003; 
Blackie et al., 2009). Because we did not have access to the automated 
interferometer, the Guillon-Keeler grading scale (Craig and Tomlinson, 1997) was 
adopted for evaluating interferometric lipid videos of the K5M.  
 
Table 2.2   The Guillon-Keeler grading scale 
 
Grade Description LLT 
1. Open meshwork Indistinct, gray, marble-like pattern, frequently visible only by 
the post-blin movement. 
≈ 15nm 
2. Closed meshwork Well defined, gray, marble-like pattern with a tight meshwork. ≈ 30nm 
3. Wave pattern Constantly changing, wave-like pattern. ≈ 30-80nm 
4. Amorphous Blue-whitish appearance with no discernible features. ≈ 80nm 
5. Colour fringes Appearance of coloured interference fringes. ≈ 80-300nm 
LLT = lipid layer thickness. 
 
The Guillon-Keeler grading scale is a validated grading scale with moderate inter- 
and intra-examiner agreement (Guillon, 1998; Nichols et al., 2002). It classifies the 
lipid layer into five grades (by texture and colour of the observed lipid layer) (Table 
2.2), where grade 1 (open meshwork) represents the lowest LLT and grade 5 (colour 
fringes) the highest (Craig and Tomlinson, 1997).  
Videos of the lipid layer were recorded using the “Lipid Layer” software of the K5M at 
a modified magnification of 1.4x and for the duration of three non-forceful blinks 
(Figure 2.10). To ensure that the blinks were not forced, the participant was 




the next measure. In case of observing a lipid layer with overlapping patterns, the 
most predominant pattern was considered for the analysis of LLT. 
 
Figure 2.10  Colour fringe LLT observed with the Keratograph 5M 
LLT = lipid layer thickness. 
The LLT was evaluated using the Lipid Layer TF-Scan software of the Keratograph 5M. The Keratograph 5M 
reflective graticule was carefully focused on the tear lipid layer, centrally to the cornea. A lipid layer video was 
recorded for the duration of three non-forceful eyelid blinks. 
 
2.2.5.8 Tear film stability 
The number of seconds that elapse between the last blink and the appearance of the 
first tear film disruption is the so-called tear film break-up time (BUT) (Norn, 1969; 
Lemp et al., 1970), which constitutes the most commonly employed clinical test to 
evaluate tear film stability (Wolffsohn et al., 2017). 
The BUT has been performed either invasively (FBUT) or noninvasively (NIBUT). 




tear film disruptions as areas of dye discontinuity. In contrast, non-invasive methods 
are based on the detection of any distortions of a reflected pattern from the tear film. 
Depending on the method used, BUT values of <5s (for FBUT) and <10s (for NIBUT) 
are associated with unstable tear films (Wolffsohn et al., 2017).  
By nature, the BUT is a highly variable measure (Sullivan et al., 2012) and hence 
consistency in its procedure is important. NIBUT is preferred over FBUT (Wolffsohn 
et al., 2017), as the use of sodium fluorescein alters tear dynamics and induces 
earlier tear disruptions than at a natural state (Mengher et al., 1985; Mooi et al., 
2017). Moreover, the volume of instilled fluorescein is difficult to standardise  
(Nichols, Mitchell and Zadnik, 2004).    
For the current study, the “NIKBUT” software of the K5M was used to evaluate the 
NIBUT (Figure 2.11). Infrared illuminated ring patterns were focused on the 
participant’s cornea. Recording of the reflected tear image occurred straight after 
having instructed the participant to deliver two natural blinks and keep their eyes open 
as long as possible. When the tear film was significantly broken or the participant had 
to blink again, the recording was automatically stopped and saved to be analysed. 
The K5M software showed the analysis in an outcoming window, in which the quality 
of the reflections was mapped and two measures for NIBUT were given: the time at 
the first tear break-up occurred (NIKBUT-first) and the average of all tear break-up 
incidents (NIKBUT-average). Three consecutive NIKBUT-first readings were taken 





Figure 2.11  First NIKBUT observed with the Keratograph 5M 
NIKBUT = non-invasive Keratograph tear break-up time. 
The NIKBUT was analysed with the NIKBUT TF-Scan software of the Keratograph 5M. The Keratograph 5M 
reflective graticule was carefully focused on the tear film, centrally to the cornea. Three NIKBUT values were 
taken (separated by at least 60s), and the mean was recorded. Recording always stopped at participants’ next 
blink.  
 
2.2.5.9 Ocular staining 
Ocular surface damage can be visualised following instillation of ophthalmic dyes. 
either in solution or via wetted filter paper strip. Ophthalmic dyes in current and past 
use are sodium fluorescein, rose bengal and lissamine green. Sodium fluorescein 
emits best fluorescence upon illumination through a blue excitation filter (peak 
wavelength of 495nm) with a yellow barrier filter (bandpass at 500nm) (Peterson, 
Wolffsohn and Fowler, 2006), staining epithelial cells with disrupted intercellular 
junctions (Feenstra and Tseng, 1992). Conversely, both rose bengal and lissamine 




compromised/damaged or exposed due to lack of mucus cover (Kim and Foulks, 
1999). 
In DED, ocular surface damage is considered a relatively late stage of the disease 
(Wolffsohn et al., 2017). At present, sodium fluorescein and lissamine green are 
recommended to be used simultaneously as part of the diagnosis of DED to assess 
corneal and conjunctival damage, respectively (Wolffsohn et al., 2017). Lissamine 
green has largely replaced rose bengal, as it has similar staining patterns, but is far 
less toxic and irritating to the eye (Manning, Wehrly and Foulks, 1995; Machado, 
Castro and Fontes, 2009). Furthermore, the addition of 1% lissamine green to 2% 
sodium fluorescein does not significantly alter the fluorescence of the latter and 
provides optimal corneal and conjunctival staining with only slightly less efficacy than 
a non-well-tolerated mixture of 1% rose bengal and 2% sodium fluorescein (Korb et 
al., 2008).  
In the present study, 1mg sodium fluorescein (Bio Fluoro, Bio-Tech Vision Care Pvt 
Ltd, Gujarat, India) and 1.5 mg lissamine green (Green Glo, Hub Pharmaceuticals 
Llc, California, USA) were instilled via filter paper strips. The strips were wetted with 
saline (Sensitive EyesTM Plus Saline Solution, Baush & Lomb Incorporated, New 
York, USA) and applied near to the temporal canthus of the lower eyelid margin whilst 
the participant looked up and away (Wolffsohn et al., 2017). The strips were held in 
place few seconds until the dyes dropped (through surface tension) onto the eyelid 





Figure 2.12 Lissamine green instillation via wetted filter paper strip 
The ophthalmic dye was applied via saline-wetted paper strip to the temporal eyelid canthus. The saline-
wetted paper strip was held in place few seconds until the dye dropped (through surface tension) onto the 
eyelid margin.  
 
Corneal and conjunctival staining were assessed using the “Fluo imaging” and “New 
Picture/Video” settings of the K5M. and within two (Peterson, Wolffsohn and Fowler, 
2006) and four minutes (Hamrah et al., 2011) of sodium fluorescein and lissamine 
green instillation, respectively. Fluorescein was instilled once (with the excess saline 
flicked off), whereas a whole drop of lissamine green (allowed to increase in 
concentration for 5s) was instilled twice, 5 minutes apart (Wolffsohn et al., 2017). 
Overall, ocular surface damage is clinically graded with subjective scoring systems, 
such as the Van Bijsterveld system, Oxford scheme, NEI/ Industry-recommended 
guidelines, Efron scale and Brien Hold Vision Institute Grading scale (Sook Chun and 
Park, 2014). However, for research purposes, corneal and conjunctival staining spots 




USA), following image processing (Figure 2.13 and Figure 2.14). The approach was 
based on a more continuous version of the Oxford grading scheme.   
 
Figure 2.13  Fluorescein staining image analysis with ImageJ 
A) Raw corneal staining image.  
B) Processing the blue colour channel of the raw corneal staining image.  
C) Zooming out the processed image by 75% and counting the observed staining spots.  
D) Finalized fluorescein staining image analysis.  
ImageJ was used to analyse fluorescein staining. The blue colour channel of the raw corneal staining image 







Figure 2.14  Lissamine green staining image analysis with ImageJ 
A) Raw conjunctival staining image.  
B) Processing the red colour channel of the raw conjunctival staining image.  
C) Zooming out the processed image by 75%.  
D) Counting the observed staining spots.  
ImageJ was used to analyse lissamine green staining. The red colour channel of the raw conjunctival staining 









2.2.5.10 Lid wiper epitheliopathy 
Lid wiper epitheliopathy (LWE) was first described in the upper eyelid and 
subsequently in the lower eyelid. It is defined as an alteration of the marginal 
palpebral conjunctiva that comes in contact with the ocular surface (Korb et al., 2002). 
It is diagnosed by vital staining and has been correlated to dry eye symptoms in 
contact lens wearers as well as non-contact lens wearer (Korb et al., 2002, 2005, 
2010). 
LWE occurs because of tear film deficiency between the ocular surface and the eyelid 
wipers, contributing to continuous friction between the structures (Korb et al., 2005) 
that may result in morphologically distinct staining patterns (Varikooty et al., 2015). 
This friction effect is thought to be limited to just start of each blink cycle due to aqua-
planning (Pult et al., 2015).  
LWE has recently been considered as a valuable diagnostic sign of DED (Efron et 
al., 2016; Wolffsohn et al., 2017). For the present study, LWE was evaluated by 
everting both eyelids and measuring the extent of lissamine green staining. Sufficient 
dye was instilled to ensure the visualization of the Marx line along the eyelid margin 
(Doughty et al., 2004), and the “New Image/Video” setting of the K5M was selected. 
The width and the length of the LWE staining were objectively analysed with ImageJ 
and classified according to the Korb four-point grading scale (For LWE width: score 
0: 25% wide LWE staining; score 1: 25 – 49% wide LWE staining; score 2: 50 – 74 
% wide LWE staining: score 3: ≥75% wide LWE staining) (For LWE length: score 0: 
<2 mm long LWE staining; score 1: 2 – 4 mm long LWE staining; score 2: 5 – 9 mm 
long LWE staining: score 3: >10 mm long LWE staining) (Korb et al., 2005) (Figure 




scale) has shown a specificity of 96% and sensitivity of 48% of symptomatic DED 
(Shiraishi, Yamaguchi and Ohashi, 2014).  
 
Figure 2.15  LWE staining image analysis with ImageJ 
LWE = lid wiper epitheliopathy.  
A) Raw LWE staining image of the upper eyelid.  
B) Measuring the length of the observed lid wiper epitheliopathy (L = 908 pixels).  
C) Measuring the width of the observed lid wiper epitheliopathy (WLWE = 10 pixels). 
D) Measuring the total width of the lid wiper (WLW = 54 pixels).  
An upper LWE length of 18.5mm and upper LWE width of 18.5% were observed. The LWE length was 
calculated using a scale convertor of 1 mm = 49 pixels (L /49). The LWE width percentage was obtained by 






2.2.5.11 Meibomian gland dysfunction 
Meibomian gland dysfunction (MGD) is defined as “chronic, diffuse abnormality of the 
meibomian glands, commonly characterized by terminal duct obstruction and/or 
qualitative/ quantitative changes in the glandular secretion” (Daniel Nelson et al., 
2011). It is considered a major cause of EDE, whereby the tear lipid layer loses 
subsequently its protective role in surface desiccation (Lemp et al., 2007).  
Meibomian glands are tubuloacinar, holocrine glands that are located within the 
upper and lower eyelid tarsal plates (Bron et al., 2004). They are similar to sebaceous 
glands of the skin, but not related to hair follicles (Knop et al., 2011). The duct orifices 
of the meibomian glands open just anterior to the mucocutaneous junction at the lid 
margins (Bron et al., 2004).  
Meibomian glands’ secretion is known as meibum (Bron et al., 2004). The meibum is 
composed by polar and non-polar lipids (Green-Church et al., 2011) and is believed 
to be regulated by hormonal and neural influences as well as the contraction of 
palpebral muscles (Knop et al., 2011). Within a blink, the secreted lipids are released 
and spread onto the ocular surface to form the lipid layer of the tear film (Bron et al., 
2004).  
In clinical practice, meibography consists of infrared-imaging of the morphological 
silhouettes of the meibomian glands of the everted eyelids (Arita et al., 2008). For the 
present study, the technique was performed using the “Meibography Upper/Lower 
Lid” setting of the K5M. The absence of the meibomian gland (meibomian gland 
dropout) was evaluated in both eyelids and graded with a currently recommended 
(Wolffsohn et al., 2017) and highly reproducible five-point meiboscale: the 




meibomian gland area; score 3: 26 – 50% loss of meibomian gland area; score 4: 51 
– 75% loss of meibomian gland area; score 5: >75% loss of meibomian gland area) 
(Pult and Riede-Pult, 2013). The relative areas of meibomian gland dropout were 
previously obtained with ImageJ, dividing the area with no visible glands by the total 
area of the tarsal conjunctiva (Pult and Riede-Pult, 2013) (Figure 2.16). 
 
Figure 2.16  MGD analysis with ImageJ 
MGD = meibomian gland dysfunction.  
A) Meibography of the upper eyelid.  
B) Measuring the total everted area of the upper tarsal conjunctiva (AT = 305890 pixels).  
C) Meibomian the area of Meibomian dropouts of the upper tarsal conjunctiva (AD = 52129 pixels).  
 
A MGD of 17.0% was observed. The MGD severity was obtained by dividing the area of meibomian dropouts 





3. CHAPTER 3: THE PREVALENCE OF DRY EYE DISEASE IN THE UK 
3.1 Overview 
The chapter gives an overview of DED in Birmingham (UK). It includes data about 
the disease prevalence by different diagnostic criteria. 
3.2 Introduction 
The primary importance of prevalence rates is to gain an understanding of a disease 
burden to further plan and allocate health sources (Mann, 2003).  
In DED, current cross-sectional studies have unfortunately relied on different 
diagnoses rendering incomparable conclusions about the disease prevalence  
(Stapleton et al., 2017). Reported DED prevalence rates have widely ranged from 
1.3% to 52.9% (Stapleton et al., 2017). 
The most consistent diagnostic criteria in the literature has been that first adopted by 
the WHS (Stapleton et al., 2017). Other diagnostic methods have determined the 
disease either by the presence of its symptoms, signs or both symptoms and signs 
(Stapleton et al., 2017). Details about all methods can be found in Chapter 1 (sections 
1.6.1 - 1.6.4). 
In view of standardisation, the TFOS DEWS II proposed a global diagnosis of DED 
(Wolffsohn et al., 2017). This identifies an individual as having DED by the presence 
of one ocular sign (determined either by assessing the tear film stability, tear film 
osmolarity, or ocular surface staining) and a positive result from a validated 




The present study is the first population-based study in the UK that estimates the 
prevalence of DED following the TFOS DEWS II diagnostic recommendations. 
Moreover, it determines the prevalence of DED by the WHS criteria to understand to 
which extent the TFOS DEWS II diagnostic criteria differs from past diagnostic 
techniques of the disease. 
3.3 Methodology 
The study methodology described in Chapter 2 was used to study the prevalence of 
DED by the WHS and TFOS DEWS II criteria. The WHS criteria defined DED by self-
report of ocular dryness and irritation either often or constantly, or a previous clinical 
diagnosis of the disease (Schaumberg et al., 2009; Uchino et al., 2011; Zhang, Chen 
and Wu, 2012; Ahn et al., 2014). The TFOS DEWS II criteria (Wolffsohn et al., 2017) 
defined DED by an OSDI score of ≥13 or DEQ-5 score of ≥6 and either one of the 
following signs:  
• Non-invasive tear breakup time of <10s; 
• Tear film hyperosmolarity defined either by the highest osmolarity value of 
≥308 mOsm/l among eyes or an interocular osmolarity difference of >8 
mOsm/l; 
• Ocular surface damage defined either by >5 corneal staining spots, >9 
conjunctival staining spots, or a lower/upper LWE staining of ≥2 mm length 
and ≥25% width. 
For the present study, the TFOS DEWS II criteria was adopted for a NIKBUT value 
of <8s. The rationale of considering this cut-off value is based on the fact that the 
K5M has shown to detect tear breakup times 2s earlier than subjective methods (for 
what a tear breakup time of <10s was originally set for) (Markoulli et al., 2018). Also, 




values when using objective measurements (Wolffsohn et al., 2017). The report 
stated that tear break-up times “can be as low as 2.7s for automated algorithms, and 
up to 10s for subjective observation techniques” (Wolffsohn et al., 2017). 
3.3.1 Data processing  
Collected scores of the DED questionnaires, tear film osmolarity, NIKBUT, and 
corneal, conjunctival and LWE staining were entered in a common Excel 
spreadsheet. Non-DED and DED outcomes were calculated by considering the 
above-mentioned diagnostic criteria and coded into values of 1 and 2, respectively.  
3.3.2 Statistical analysis 
Statistical analysis was performed with SPSS version 23 (IBM Corp. released in 
2015. New York. US). DED prevalence rates were stratified by sex and age decades 
and presented with their 95% CIs. Where the sample size was ≤40, Jeffrey’s interval 
corrections were made (DasGupta, Cai and Brown, 2001). Differences among 
prevalence rates were tested with McNemar’s (for paired samples) and Chi-square 
tests (for unpaired samples). Correlations between DED symptoms and signs among 
DED participants (all previously confirmed to be not normally distributed with 
Kolmogorov-Smirnov normality tests) were evaluated with Spearman’s rank 
correlation coefficients.  
3.4 Results 
Two-hundred and eighty-two Birmingham residents (43 ± 19 years, 56% females) 
participated in the study (Figure 3.1). Recruitment occurred by 60%, 30%, 6%, 3% 




Birmingham City Council and Aston Eye Clinic, respectively. Of all participants 
enrolled, thirty-one did not successfully complete the clinical assessment; either 
because they found the tests too time-consuming or too invasive.  
 
Figure 3.1 Study population distribution 
 
The study population intended to map Birmingham’s (UK) population census of 2016 
(Figure 3.2). 
 
Figure 3.2 Birmingham’s (UK) population census (2016) 
3.4.1 Dry eye prevalence by the TFOS DEWS II criteria     
The prevalence of DED by the TFOS DEWS II criteria varied with the diagnostic 
method used. DED diagnosis occurred significantly more often where ocular 


























































highest prevalence rates were observed with those diagnostic methods involving 
ocular surface staining (Figure 3.3).  
 
Figure 3.3 DED prevalence by the TFOS DEWS II criteria 
DED = dry eye disease. NIKBUT = non-invasive Keratograph tear break-up time. DEQ-5 = 5-item Dry Eye 
Questionnaire. OSDI = Ocular Surface Disease Index. 
The TFOS DEWS II criteria defined DED either by signs of tear film instability, hyperosmolarity or ocular 
surface staining, and a positive DEQ-5 or OSDI score. 
   
DED by the TFOS DEWS II criteria was found significantly more prevalent in females 
than in males (Figure 3.4). The disease also differed with age, but without statistical 
significance (Figure 3.5). 
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Figure 3.4 DED prevalence by the TFOS DEWS II criteria (stratified by sex) 
DED = dry eye disease. NIKBUT = non-invasive Keratograph tear break-up time. DEQ-5 = 5-item Dry Eye 
Questionnaire. OSDI = Ocular Surface Disease Index. 
The TFOS DEWS II criteria defined DED either by signs of tear film instability, hyperosmolarity or ocular 
surface staining, and a positive DEQ-5 or OSDI score. 
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Figure 3.5 DED prevalence by the TFOS DEWS II criteria (stratified by age) 
DED = dry eye disease. NIKBUT = non-invasive Keratograph tear break-up time. DEQ-5 = 5-item Dry Eye 
Questionnaire. OSDI = Ocular Surface Disease Index. 
The TFOS DEWS II criteria defined DED either by signs of tear film instability, hyperosmolarity or ocular 
surface staining, and a positive DEQ-5 or OSDI score. 
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3.4.2 Dry eye prevalence by the WHS criteria  
The WHS criteria estimated a DED prevalence of 29.5% (95%CI, 24.4-35.1). DED by 
the WHS criteria differed significantly with sex and age (Figure 3.6). Among all ages, 
participants of 70 to 79 years-old were the most affected by the disease. 
 
Figure 3.6  DED prevalence by the WHS criteria (stratified by sex and age) 
WHS = Women’s Health Study  
The WHS criteria defined DED by self-report of ocular dryness and irritation either often or constantly, or a 
previous clinical diagnosis of the disease. Statistically significant differences between prevalence rates 
stratified by age resulted from significant differences between DED diagnoses of participants in their 10s and 
70s (p-value ≤0.001). 
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3.4.3 Correlations between DED signs and symptoms in DED participants 
NIKBUT values were significantly correlated to the DEQ-5 and OSDI among DED 
participants (Table 3.1). In addition, both symptom questionnaires were found to be 
significantly concurrent with each other (rS, 0.518; p-value, ≤0.001).  
Table 3.1 Correlations between DED signs and symptoms in DED participants 
 











NIKBUT mean value (s) 162 -0.177* -0.175* 
Highest osmolarity value (mOsm/L) 161 -0.114 -0.107 
Interocular osmolarity difference 
(mOsm/L) 
161 -0.057 -0.034 
Corneal staining spots  161 0.124 0.095 
Conjunctival staining spots 160 0.058 0.091 
Lower LWE length (mm) 162 -0.006 -0.026 
Lower LWE width (%) 162 -0.040 -0.047 
Upper LWE length (mm) 153 0.070 -0.046 
Upper LWE width (%) 153 0.066 0.015 
DED = dry eye disease. * p-value ≤0.05. 
 
3.5 Discussion  
The epidemiology of DED has been challenged by the failure of a standardised 
diagnostic method to rely on (Stapleton et al., 2017). The present study is the first to 
determine the disease prevalence in the UK as conforming to the TFOS DEWS II 
diagnostic criteria (Wolffsohn et al., 2017). The prevalence rates were stratified by 
sex and age and compared to those obtained with the WHS criteria. 
The results showed that the prevalence of DED by the TFOS DEWS II varied 
considerably with the diagnostic method used, ranging from 19.0% to 56.3%. 
Prevalence rates were significantly higher where DED symptoms were assessed with 
the DEQ-5 than with the OSDI. Moreover, ocular surface staining was the most 




Lower prevalence rates of DED with the OSDI might be explained in the nature of the 
symptom questionnaire. As opposed to the DEQ-5, the OSDI assesses a smaller 
number of DED symptoms and hence may be less accurate in detecting symptomatic 
DED. Additionally, because the OSDI also measures the impact of environmental 
triggers on DED, it may be less simple to complete than the DEQ-5. 
Previous evidence has noted that ocular surface staining might not only be an 
intrinsic feature of DED, but may also be presented in other conditions with eventual 
DED symptoms (Stapleton et al., 2017). This might explain the higher prevalence 
rates of DED obtained when considering ocular surface staining compared to tear 
film instability or hyperosmolarity. Contrarily, the cut-off values used for corneal and 
conjunctival staining have been set somewhat subjectively (Whitcher et al., 2010), 
probably misdiagnosing DED. 
The WHS criteria determined a disease prevalence of 29.5%, with significant 
differences among sexes and age decades. The estimate was similar to those 
obtained with the TFOS DEWS II diagnostic methods based on the DEQ-5 and 
NIKBUT or tear film osmolarity. Notably, significant negative correlations between 
NIKBUT and DED symptoms highlighted the diagnostic suitability of tear film stability. 
DED prevalence by symptoms and signs has also been reported in other European 
countries. Malet et al., describing DED by an OSDI score of ≥23 or the use of daily 
artificial tears, determined a disease prevalence of 21.97% in France; 27.1% in 
females and 13.6% in males (Malet et al., 2014). A similar diagnostic method, 
involving symptom self-report and the assessment of ocular surface staining or tear 




females more affected than males (11.9% vs. 9.0%) (Viso, Rodriguez-Ares and 
Gude, 2009).  
In agreement with these studies, DED by the TFOS DEWS II criteria differed 
significantly with sex, suggesting that sex hormones may play an important role in 
the disease predisposition. At present, male-specific sex hormones have shown to 
regulate both tear lipid and aqueous secretions, as well as the immune responses of 
corneal and conjunctival cells (Sullivan et al., 2017). However, female-specific sex 
hormones appear to antagonise these functions (Sullivan et al., 2017).  
A meta-analysis on DED epidemiology has outlined that DED increases 
approximately linearly with age, with a steeper rise by decades in DED described by 
signs than by symptoms (Stapleton et al., 2017). Interestingly, the prevalence of DED 
by the TFOS DEWS II criteria was not significantly different with age, nor presented 
an obvious linear relationship. The results might have been influenced by other DED 
risk factors. 
In conclusion, differences in the DED diagnostic methods used resulted in variations 
in the disease prevalence. DED diagnosis involving the assessment of symptoms 
and tear film stability appears to be suitable and similar to the WHS criteria. The 
diagnostic method might be considered to diagnose DED on its own, reducing cost 
and time boundaries of future clinical and/or epidemiological DED studies (Savini et 







4. CHAPTER 4: THE RISK FACTORS OF DRY EYE DISEASE IN THE UK 
4.1 Overview 
The chapter gives an overview of DED in Birmingham (UK). It includes data about 
the risk factors of DED by the TFOS DEWS II diagnostic criteria. 
4.2 Introduction 
Epidemiological research on DED has focused on the assessment of risk factors to 
effectively prevent and control the disease (Stapleton et al., 2017). A risk factor refers 
to any internal or external condition of an individual, which increases the likelihood of 
developing DED (Lemp et al., 2007).  
Assessing DED risk factors requires standardisation in obtaining information about 
individuals’ health and lifestyle, as well as in differentiating between affected and 
unaffected eyes (Stapleton et al., 2017). Yet, the use of different disease diagnoses 
has hindered to reach conclusive results on DED risk factors (Stapleton et al., 2017).  
The present study is the first population-based study in the UK that estimates the risk 
factors of DED following recent diagnostic recommendations of the TFOS DEWS II 
(Wolffsohn et al., 2017).  
4.3 Methodology 
The study methodology described in Chapter 2 was used to study the risk factors of 
DED. The disease was defined as conforming to the TFOS DEWS II 
recommendations (Wolffsohn et al., 2017), more specifically, by a DEQ-5 score of ≥6 




 NIKBUT of <8s; 
 Tear film hyperosmolarity defined either by the highest osmolarity value of ≥308 
mOsm/l among eyes or an interocular osmolarity difference of >8 mOsm/l; 
 Ocular surface staining defined by >5 corneal spots, >9 conjunctival spots or 
lower/upper LWE staining of ≥2 mm length and ≥25% width. 
4.3.1 Data processing  
Risk factors gathered by the DERFS questionnaire were treated as nominal or ordinal 
variables and coded into numerical scores (Table 4.1). Risk categories with a low 
frequency of endorsement (less than 5%) were collapsed (rather than being excluded 
from the start) for the statistical analysis.  
Table 4.1  Recording of DED risk factors 
 
DERFS question Risk factor Coding instructions  
 
 
To which group do you 
belong? 
Ethnicity 1= White, 2= Asian, 3= Black, 4= Others.  
Sex 1= Male, 2= Female. 
Age  1= 10s, 2= 20s, 3= 30s, 4= 40s, 5= 50s, 
6= 60s, 7= 70s, 8= 80s.  
Residential area 1= Rural, 2= Urban. 
Education 1= Elementary or primary school,  
2= Middle or secondary school, 3= High 
school or 6th form, 4= University o higher. 
Do you work? Employment status 1= Unemployed, 2= Employed. 
Do you smoke? Smoking  1= No, 2= Yes. 
Do you drink alcohol? Alcohol intake 1= No, 2= Yes. 
Do you wear contact 
lenses? 
Contact lens wear 1= No, 2= Yes. 
Do you use computer? Computer use 1= <3 hours/day, 2= 3-5 hours/day, 3= 6-
8 hours/day, 4= >8 hours/day. 





1= No, 2= Yes. 
→ Code 2 included any health 
condition/problem described by the 
participants.  
Do you have had any 
eye surgery? 
Ocular surgery 1= No, 2= Yes. 
→ Code 2 included any past ocular 
surgery described by the participants. 
Do you take any 
medication regularly? 
Medication intake 1= No, 2= Yes. 
→ Code 2 included any medication 
described by the participants. 
Do you take any 
nutritional supplement 
regularly? 
Nutritional supplement intake 1= No, 2= Yes. 
→ Code 2 included any nutritional 
supplement described by the participants. 










   
Table 4.2 (continued) 
 
How much sleep do you 
get? 
Sleep quality 1= >8 hours/night, 2= 6-8 hours/night,  
3= <6 hours/night 
How much do you spend 
outdoors on a regular 
leisure day? 
Outdoor activity 1= <3 hours/leisure day, 2= 3-4 
hours/leisure day, 3= >4 hours/leisure 
day. 
How stressful are your 
days? 
Stress level 1= Least stressful, 2= Moderately 
stressful, 3= Extremely stressful. 
 
4.3.2 Statistical analysis 
Statistical analysis was performed with SPSS version 23 (IBM Corp, released in 
2015, New York, USA). Univariate analysis, including Chi-square tests, initially 
determined the significance of all self-reported risk factors. Risk factors with p-values 
of less than 0.10 were considered for further multivariate analysis using non-
hierarchical enter binary logistic regression. Correlations between the selected risk 
factors were evaluated with point biserial correlation coefficients (between 
dichotomous and ordinal risk factors), Spearman’s rank correlation coefficients 
(between two ordinal risk factors) and phi coefficients (between two dichotomous risk 
factors). Finally, the strength and precision of the DED risk factors were summarised 
using ORs and 95% CIs, respectively. ORs with p-values of ≤0.05 were considered 
statistically significant.  
4.4 Results 
Two-hundred and eighty-two Birmingham residents (43 ± 19 years, 56% females) 
participated in the study (Table 4.2). Recruitment occurred mostly at Aston University 
campus. Clinical assessments and DERFS questionnaires were successfully 





Table 4.2 Study population characteristics  
 

















































Education Elementary or primary 
school 
Middle or secondary 
school 
High school or 6th form 



































































































































Table 4.2 (continued) 
 
* Recorded health conditions/problems were migraine (n =31), asthma (n =31), eczema (n =23), acne (n 
=17), rosacea (n =9), psoriasis (n =3), dermatitis (n =1), morphea (n =1), vitiligo (n =1), vitamin D deficiency 
(n =28), iron deficiency (n =11), anxiety (n =25), depression (n =15), rheumatoid arthritis (n =28), 
hypertension (n =27), hypercholesterolemia (n =20), thyroid disease (n =14), cancer (n =13), polycystic 
ovary syndrome (n =4), bladder irritation (n =1), osteoporosis (n =5), irritable bowel syndrome (n =9), 
diabetes mellitus (n =11), lymphatic drainage problem (n =1), stroke (n =4), prostatitis (n =1), gout (n =1), 
keratoconus (n =1), pterygium (n =1), insomnia (n =2), Sjögren syndrome (n =1), tuberculosis (n =1), 
epilepsy (n =1), Ehlers-Danlos syndrome (n =1), sinusitis (n =2), familial dilated cardiomyopathy (n =1), 
Crown disease (n =1), Carpal tunnel syndrome (n =1), glaucoma (n =4), human immune deficiency virus 
(n =1), multiple sclerosis (n =1), thoracic outlet syndrome (n =1), audio sclerosis (n =1), diverticulosis (n 
=1), rhinitis (n =1), bronchiectasis (n =1), Best disease (n =1), age-related macular degeneration (n =1), 
Parkinson (n =1), traumatic glaucoma (n =1), ulcerative colitis (n =1), retinopathy (n =1), spinal stenosis 
(n =1). cataracts (n =1), pain in joints (n =1), back (n =8), pelvic (n =3) and hips (n =1), and allergy to 
pollen (n =44), grass (n =3), dust (n =12), penicillin (n =11), pets (n =7), nuts (n =3), feathers (n =2), flowers 
(n =1), wool (n =1), mould (n =1), mites (n =2), plasters (n =2), antibiotics (n =1), non-steroidal anti-
inflammatory drugs (n =1), gluten (n =1), diary (n =1), soy (n =1), fish (n =1), eggs (n =1), zinc (n =1), 
statins (n =1), trimethoprim (n =1), efortil (n =1), morphine (n =1) inhaler (n =1) and opioids (n =1). 
** Documented surgical ocular interventions were strabismus surgery (n =4), refractive surgery (n =13), 
dacryocystorhinostomy (n =2), cyst removal (n =7), corneal cross-linking (n =1), cataract surgery (n =11) 
and retinal surgery (n =2). 
*** Medication intake included the use of oral contraceptives (n =18), antimigraine drugs (n =4), 
antihistamine drugs (n =22), pills for skin problems (n =7), antihistamine inhaler (n =11), anxiolytics (n 
=3), steroids (n =2), painkillers (n =7), blood pressure pills (n =19), anti-thyroid pills (n =11), pills for 
asthma (n =1), pills for digestive problems (n =2), pills for bladder control (n =4), cancer treatment (n =2), 
antidepressant (n =8), statins  (n =19), diuretics (n =2), hormone therapy (n =3), pills for irritable bowel 
syndrome (n =1), diabetes treatment (n =6), aspirins (n =12), prostatitis treatment (n =2), heart treatment 
(n =1), pills for vertigo (n =1), sleeping tablets (n =5), dermatitis treatment (n =1), arthritis treatment (n 
=2), antibiotics (n =2), glaucoma drops (n =3), pills for palpitation (n =1), beta blockers (n =1), human 
immune deficiency virus treatment (n =1), osteoporosis treatment (n =1), stomach protector (n =3), 
antifungal pills (n =1), antihistamine nasal spray (n =1), antihistamine eyedrops (n =2), Parkinson 
treatment (n =1), morphine (n =1), epilepsy treatment (n =1), sinusitis nasal spray (n =1), gout treatment 
(n =1), and contraceptive implant (n =2). 
**** Nutritional supplement intake include the use of vitamin D (n =42), cod liver oil (n =37), iron (n =22), 
proteins (n =4), multivitamins (n =44), vitamin C (n =16), vitamin B (n =9), calcium (n =5), zinc (n =2), 
vitamin E (n =1), weight gainer (n =1), folic acid (n =2), echinacea (n =1), glucosamine (n =11), hyaluronic 
acid (n =1), probiotics (n =1), herbal pills (n =1), magnesium (n =7), primrose oil (n =1), caffeine (n =1), 
essential amino acids (n =1), electrolytes (n =1), melatonin (n =1), collagen (n =1), lutein (n =2), yin yang 
(n =1), flaxseed oil (n =1), lysine (n =1), beetroot extract (n =1), turmeric (n =1) and Adalat (n =1). 
 
4.4.1 Dry eye risk factors 
Sex, age, employment status, health conditions/problems, medication intake, sleep 
quality and outdoor activity were considered for the multivariate analysis (Table 4.3). 
Risk factors which did not initially reach significance included ethnicity, residential 
area, education, smoking, alcohol intake, contact lens wear, computer use, ocular 






Table 4.3 Distribution of risk factors among non-DED and DED participants   
 
Risk factor Category Nnon-DED NDED NTotal X2 p-value 
Ethnicity White 
Asian 


























































Education Elementary, primary, 
middle or secondary 
school 
High school or 6th 
form 






























































































































































DED = dry eye disease. n = sample size. X2 = Chi-square test.  
*Selected for logistic multivariate analysis. 
 
DED associations that were identified statistically significant in the multivariate 
analysis were female sex, the presence of any health conditions/problems, poor 




Table 4.4 Risk factors for DED  
 
Risk factor Univariate analysis Multivariate analysis 
























































































































middle or secondary 
school 
High school or 6th form 







































































































































































































































Table 4.4 (continued) 
 






















































































DED = dry eye disease. OR = odds ratio. CI = confidence interval. n/a =not applicable. 
 
4.4.2 Correlations between dry eye risk factors  
Most of the selected DED risk factors were significantly correlated with age (Table 
4.5). Health conditions/problems showed a significant positive and negative 
association with medication intake and outdoor activity, respectively (Table 4.5). A 
significant positive correlation was also observed between employment status and 
outdoor activity (Table 4.5).    
Table 4.5 Correlations between DED risk factors   
Correlations 
coefficient 











 Sample size 
Sex  0.002 -0.070 0.080 0.063 0.006 -0.052 
 282 274 274 274 273 267 
Age   -0.059 0.347* 0.341** 0.150* -0.094 
 274 274 274 273 267 
Employment status    -0.093 -0.051 0.093 0.192** 
 274 274 273 267 
Health 
conditions/problems 
    0.385*** 0.038 -0.135* 
 274 273 267 
Medication intake      0.050 -0.146 
 273 267 
Sleep quality       0.025 
 266 
DED = dry eye disease. * p-value ≤0.05. ** p-value ≤0.01. *** p-value ≤0.001. 






The present study is the first to identify DED risk factors as conforming to the TFOS 
DEWS II diagnostic criteria (Wolffsohn et al., 2017). The criteria is evidence-based 
and currently recommended to be globally applied in DED research (Wolffsohn et al., 
2017).  
The cross-sectional study design used allowed to evaluate different DED 
associations simultaneously (Mann, 2003). The associations were assessed in 
previous cross-sectional studies, whereby the disease was diagnosed either by the 
WHS criteria, symptoms, signs or both symptoms and signs (Stapleton et al., 2017). 
Participants' characteristics were gathered through the DERFS in order to record 
more precisely the risk factors (Wolffsohn et al., 2017). 
The result showed that age, employment status, medication intake, female sex, the 
presence of any health conditions/problems, poor sleep quality and prolonged 
outdoors activity were potential risk factors for DED (p-values <0.20). The statistical 
significances of the last four factors were confirmed in the multivariate analysis (p-
values ≤0.05).   
In agreement with previous studies (Jie et al., 2009; Han et al., 2011; Ahn et al., 
2014), females were 2.317 times significantly more likely to present DED than males, 
reflecting the importance of sex hormones in the disease predisposition. Male-
specific sex hormones are believed to regulate both tear lipid and aqueous 
secretions, as well as the immune responses of corneal and conjunctival cells 
(Sullivan et al., 2017). In contrast, female-specific sex hormones appear to 




Health conditions/problems, including hypertension, hypercholesterolemia, thyroid 
disease, asthma, eczema, any allergy, rheumatoid arthritis, stroke, migraine, irritable 
bowel syndrome and pelvic pain, have been significantly related to DED (Ahn et al., 
2014; Vehof et al., 2014). The same health conditions/problems were reported in the 
present study. Nevertheless, the rationale behind the relationship between each 
health condition/problem and DED is difficult to ascertain, as these were studied in 
conjunction.  
Sleeping less than 6 hours/night contributed significantly to DED (OR = 5.050), as in 
(Ahn et al., 2014). Short sleep duration is thought to decrease parasympathetic 
activity (Tobaldini et al., 2017). The lacrimal gland is mostly innervated by the 
parasympathetic nervous system (Belmonte et al., 2017), and hence any kind of 
sleep disturbance may considerably lessen tear secretion. 
Participants engaging in out of doors for more than four hours on a regular leisure 
day were 2.369 times significantly more prone to DED. Outdoors activity can be 
related to environmental conditions, such as high altitude, sunlight exposure, 
temperature, humidity, wind, precipitation and air pollution, that have been 
associated with symptomatic and clinically diagnosed DED (Lu et al., 2008; Guo et 
al., 2010; Um et al., 2014).  
Although the statistical significance of age, employment and medication intake 
disappeared in the multivariate analysis, this does not mean that the risk factors have 
no clinical importance (Offord and Kraemer, 2000). Their contributions might have 
been influenced by inter-correlations observed with other risk factors that remained 




Importantly, risk factors which did not initially reach significance in the univariate 
analysis, including ethnicity, residential area, education, contact lens wear, computer 
use, ocular surgery and stress level, might have been confounded by random 
sampling. Recruitment occurred mostly at Aston University, showing a strong 
University population profile. The participants were predominantly non-contact lens 
wearers, computer users and/o non-smokers, with moderate stress and/or no history 
of ocular surgery. 
In conclusion, female sex, the presence of any health condition/problem, poor sleep 
quality and prolonged outdoor activity were significant risk factors for the DED. Future 
DED research, using the TFOS DEWS II diagnostic criteria in other study 
populations, would be of great value to better understand the disease burden 






5. CHAPTER 5: SUBCLASSIFICATION OF DRY EYE DISEASE IN THE UK 
5.1 Overview  
The chapter gives an overview of DED in Birmingham (UK). It includes data about 
the prevalence and potential risk factors of DED subtypes.  
5.2 Introduction 
Prevalence studies assessing risk factors of ADDE and EDE may be useful to develop 
an effective treatment plan for both DED subtypes (Jones et al., 2017). Both ADDE and 
EDE have similar ocular symptoms and general DED signs, however, they may be 
related to different risk factors and hence require a different therapeutical approach 
(Jones et al., 2017).  
Recent evidence on DED classification supports the hypothesis that ADDE and EDE 
may coexist with increasing disease severity and thus characteristics of each need 
to be considered in clinical practice (Craig et al., 2017). Tests specific to ADDE and 
EDE evaluate the tear film volume (including the PRT test, Schirmer test and TMH) 
and tear film evaporation, lipid layer thickness and meibomian gland dysfunction, 
respectively (Wolffsohn et al., 2017). The tests should not override a clinical 
diagnosis of DED but should assist in the disease amelioration (Wolffsohn et al., 
2017).  
Unfortunately, although specific clinical tests have been assigned to diagnose ADDE 
and EDE, there is no apparent consistency in categorizing both DED subtypes (Jones 
et al., 2017). For instance, in DED epidemiology, different sub-classification cut-off 
values were used, hindering direct comparisons of prevalence rates of ADDE and 




5.1). Moreover, the disease diagnosis has been generally addressed somewhat 
subjectively (Wolffsohn et al., 2017) (Table 5.1). 
Table 5.1 Previous large-scale clinical-population-based studies on DED subtypes 
 
Study Population DED subtypes 
 characteristics ADDE EDE 









♀ 912  










meibum, and  
PRT test of <10 
mm/ 15s and 
TMH of <0.10 
mm. 







PRT test of ≥10 
mm/ 15s and 





46.3 ± 16.9  
♀ 218  
♂ 81  
MGD score of ≤5 
and Schirmer test 
II of <7 mm/5 min 
10.3 [n/a] MGD score of >5 
and Schirmer test 





♀ 2585  






Schirmer test II of 
<10 mm/ 5 min 





Schirmer test II of 












and cloudy or 
toothpaste-like 
meibum, and 
Schirmer test I of 









Schirmer test I of 
>5 mm/5 min   
11.6 [n/a]† 
7.0 [n/a]‡ 
DED = dry eye disease. ADDE = aqueous deficient dry eye. EDE = evaporative dry eye. PRT = phenol red 
thread. TMH = tear meniscus height. n/a = not applicable. 
A. DED was defined by at least one of five primary symptoms of the MQ questionnaire (soreness, 
scratchiness, dryness, grittiness and burning) either often or constantly, an FBUT of <10s and a rose bengal 
score of ≥1 (van Bjisterveld staining score) (Albietz, 2000). 
B. DED was defined by an OSDI score of ≥5 and at least two of five signs: FBUT <7s, Schirmer test I <7 
mm/5 min, corneal staining >0 (National Eye Institute/Industry Workshop scale), conjunctival staining >0 
(National Eye Institute/Industry Workshop scale) and meiboscore of >5 (Bron/Foulks scoring system) 
(Sullivan et al., 2010; Lemp et al., 2012). 
C. DED was defined by presenting a MQ score of ≥14.5 (Rege et al., 2013). 
D. DED was classified into symptomatic† and asymptomatic‡ DED. Symptomatic DED was defined by an 
OSDI score of ≥13 and fluorescein tear break-time of <10s or corneal and conjunctival fluorescein staining 
of ≥1 (Oxford grading scale). Asymptomatic DED was defined by an OSDI score of <13 and fluorescein 
tear break-time of <10s or corneal and conjunctival fluorescein staining of ≥1 (Oxford grading scale) 
(Asiedu, Dzasimatu and Kyei, 2018).  
 
A standardized DED diagnosis is crucial to attempt towards an accurate disease 




diagnostic criteria (Wolffsohn et al., 2017) and recommended its use with additional 
sub-classification tests. The sub-classification tests included measurements of TMH, 
LLT, tear evaporation and MGD (Wolffsohn et al., 2017), however, they had no 
established diagnostic cut-off values. 
The present study is the first in proposing a sub-classification system (with 
established cut-off values) for DED that follows current diagnostic recommendations 
of the TFOS DEWS II. The sub-classification system was subsequently used to 
determine the prevalence and potential risk factors of ADDE and EDE among a single 
population of UK. 
5.3 Methodology 
The study methodology described in Chapter 2 was used to study the prevalence 
and potential risk factors of DED subtypes. DED was diagnosed by the TFOS DEWS 
II criteria (Wolffsohn et al., 2017). The criteria defined the disease by an OSDI score 
of ≥13 or DEQ-5 score of ≥6 and either the presence of: 
• Tear film instability (determined by a NIKBUT of <8s); 
• Tear film hyperosmolarity (characterized either by the highest osmolarity 
value of ≥308 mOsm/l among eyes or an interocular osmolarity difference of 
>8 mOsm/l);  
• Ocular surface damage (described either by >5 corneal staining spots, >9 
conjunctival staining spots, or a lower/upper LWE staining of ≥2 mm length 





Measurements of tear evaporation, TMH, LLT and lower/upper MGD were assessed 
to aim DED classification, as suggested by the TFOS DEWS II  (Wolffsohn et al., 
2017). In line with current definitions of ADDE and EDE (Craig et al., 2017), ADDE 
was described by a reduced TMH, whereas EDE was described by a reduced LLT or 
an increased tear evaporation or lower/upper MGD (Wolffsohn et al., 2017). 
MGD has been previously graded by the quality of the meibum, more specifically, by 
its expressibility and appearance (Albietz, 2000; Rege et al., 2013; Asiedu, 
Dzasimatu and Kyei, 2018). In the present study, the condition was defined by 
meibomian gland dropouts. Meibomian gland dropouts have been previously 
correlated with altered meibum  (Finis et al., 2015) and hence explains the rationale 
behind the used approach. Besides, it was believed that the meibum might have been 
already confounded by previous tests involving eyelid eversion and the instillation of 
ocular dyes.  
Sex, age, employment status, health conditions/problems, medication intake, sleep 
quality and outdoor activity were gathered by the DERFS questionnaire (section 
2.2.5.2) and considered in the risk factor analysis of both DED subtypes. As resulted 
from Chapter 4, the factors have shown to be significant risk factors of DED and, 
amongst these, sex and health conditions/problems had the greatest statistical 
significance (p-value ≤0.01).  
Sub-classification tests cut-off values were determined from tear evaporation, TMH, 
LLT and MGD readings of non-DED participants. The readings were initially stratified 
by sex and by the presence/absence of health conditions/problems to understand 
whether both factors might have confounded normal tear film characteristics. 




differential diagnosis of DED (Wolffsohn et al., 2017), the study aimed to adopt cut-
off values that were as specific as possible. 
5.3.1 Data processing 
Collected scores of DED and DERFS questionnaires, tear evaporation, tear 
osmolarity, NIKBUT, TMH, LLT, ocular staining and MGD were entered in a common 
Excel spreadsheet. Initial and differential diagnoses of DED were performed in 
participants that have successfully completed the clinical assessment. Negative and 
positive diagnoses were coded as values of 1 and 2, respectively. A dichotomous 
variable encompassing purely positive EDE and ADDE outcomes was created to 
study the risk factors of both DED subtypes. Risk factors were identically categorized 
as in Chapter 4. 
5.3.2 Statistical analysis 
Statistical analysis was performed with SPSS version 23 (IBM Corp. released in 
2015. New York. US). All ocular parameters were confirmed to be not normally 
distributed using Kolmogorov-Smirnov tests. Differences between ADDE and EDE 
signs of female and male non-DED participants with and without health 
conditions/problems were analysed with U-Mann Whitney tests. Prevalence rates of 
DED subtypes were presented with 95% CIs. Associations between ADDE and EDE 
signs and between the sub-classification signs and DED symptoms of DED 
participants were evaluated with Spearman’s rank correlation coefficients. Finally, 
within DED participants, risk factors of pure ADDE and EDE were determined through 
phi (for dichotomous risk factors) and point biserial correlation coefficients (for ordinal 





Two-hundred and eighty-two Birmingham residents (42.4 ± 18.7 years, 56% females) 
participated in the study. Recruitment occurred mostly at Aston University campus. 
DERFS questionnaires were successfully completed by 96% participants. One 
hundred and sixty-two positive and one hundred and six negative diagnoses of DED 
were concluded. Missing data resulted from any instrumentation failure or 
participants’ poor collaboration in the clinical assessment. 
5.4.1 Dry eye sub-classification signs of non-dry eye participants 
Measurements of tear evaporation, TMH, LLT and lower/upper MGD of non-DED 
participants with health conditions/problems differed significantly among females and 
males (Table 5.2). However, this was not the case for non-DED participants without 
health conditions/problems. 
Table 5.2 DED sub-classification signs of non-DED participants (stratified by sex and the 





(mean ± SD) Without health conditions/problems With health conditions/problems 





















































5.4.2 Cut-off values of dry eye sub-classification tests 
The diagnostic cut-off values of the sub-classification tests were based on the 
distribution of tear evaporation rates, TMH, LLT and upper/lower MGD of non-DED 
participants without health conditions/problems. These were:  
• Tear evaporation of >46 g/m2/h (Figure 5.1); 
• TMH of <0.2 mm (Figure 5.2);  
• LLT of grade <3 (Figure 5.3);  
• Upper/lower MGD of >28% (Figure 5.4);  
Non-DED participants without health conditions/problems were selected to ensure 
that the cut-off values were applicable for both sexes (section 5.4.1). 
5.4.3 Sub-classification of dry eye disease  
DED participants with a TMH of <0.2 mm and a normal tear evaporation rate (≤46 
g/m2/h), LLT (a grade of ≥3) and lower/upper MGD (≤28%) were diagnosed with 
ADDE. In contrast, EDE was defined by a tear evaporation rate of >46 g/m2/h, LLT 
of grade <3 and lower/upper MGD of >28%, but a normal TMH (≥0.2 mm).  
Where the criteria of both ADDE and EDE was met, DED was classified into a third 
disease subtype representing an aqueous-deficient/evaporative DED. Conversely, 
where the criteria of both ADDE and EDE was not met, DED was classified into an 







Figure 5.1 Tear evaporation distribution of healthy non-DED participants  
EDE = evaporative dry eye; DED = dry eye disease. 
(A) Frequency plot of tear evaporation measurements of healthy non-DED participants. 
(B) Box plot of tear evaporation measurements of healthy non-DED participants.  
First quartile = 32 g/m2/h; Median = 39 g/m2/h; Third quartile = 46 g/m2/h; Minimum = 11 g/m2/h; 
Maximum = 67 g/m2/h. 
The tear evaporation cut-off value was set at 46 g/m2/h. The cut-off value was based on the third quartile 
of the tear evaporation distribution referring 35 of 45 non-DED participants as non-EDE. The approach 









Figure 5.2 TMH distribution of healthy non-DED participants  
TMH = tear meniscus height; ADDE = aqueous deficient dry eye; DED = dry eye disease. 
(A) Frequency plot of TMH measurements of healthy non-DED participants. 
(B) Box plot of TMH measurements of healthy non-DED participants. 
First quartile = 0.203 mm; Median = 0.280 mm; Third quartile = 0.340 mm; Minimum = 0.004 mm; 
Maximum = 0.546 mm. 
The TMH cut-off value was set at 0.2 mm. The cut-off value was based on the first quartile of the TMH 
distribution referring 35 of 46 non-DED participants as non-ADDE. The approach used allowed to infer 












Figure 5.3 LLT distribution of healthy non-DED participants  
LLT = lipid layer thickness; EDE = evaporative dry eye; DED = dry eye disease. 
(A) Frequency plot of LLT measurements of healthy non-DED participants. 
(B) Box plot of LLT measurements of healthy non-DED participants. 
First quartile = 3.00; Median = 4.00; Third quartile = 4.00; Minimum = 1.50; Maximum = 5.50. 
The LLT cut-off value was set at a grade of 3. The cut-off value was based on the first quartile of the LLT 
distribution referring 38 of 46 non-DED participants as non-EDE. The approach used allowed to infer the 















Figure 5.4 MGD distribution of healthy non-DED participants  
MGD = meibomian gland dysfunction; EDE = evaporative dry eye; DED = dry eye disease. 
(C) Frequency plot of lower/upper MGD measurements of healthy non-DED participants. 
(D) Box plot of lower/upper MGD measurements of healthy non-DED participants. 
For lower MGD: First quartile = 9.25%; Median = 17.50%; Third quartile = 28.00%; Minimum = 
18.88%; Maximum = 56.13%. For upper MGD: First quartile = 13.00%; Median = 20.00%; Third 
quartile = 28.00%; Minimum = 9.50%; Maximum = 50.50%. 
The MGD cut-off value was set at a grade of 28%. The cut-off value was based on the third quartile of 
the lower MGD and upper MGD distribution referring 35/46 and 35/45 of non-DED participants as non-
EDE, respectively. The approach used allowed to infer the highest possible test specificity of 76.1% 




5.4.4 Prevalence of dry eye subtypes 
DED was classified either into unclassified DED (18.5%), EDE (64.2%), ADDE (6.2%) 
and both ADDE and EDE (11.1%) (Figure 5.5). Amongst all, EDE was the most 
prevalent DED subtype.  
 
Figure 5.5 Prevalence of DED subtypes 
DED = dry eye disease. EDE = evaporative dry eye. ADDE = aqueous deficient dry eye.  
 
5.4.5 Frequency of evaporative dry eye signs in evaporative dry eye 
participants 
MGD was the most commonly observed EDE sign, followed by increased tear 
evaporation and decreased LLT (Figure 5.6). Of all EDE participants, 45.2% (47/104) 
presented a combination of EDE signs (Figure 5.6).  
18.5% (95%CI, 12.5-24.5); 30/162
64.2% (95%CI, 56.8-71.6); 104/162
6.2% (95%CI, 2.5-9.9); 10/162





































Figure 5.6 Frequency of EDE signs in EDE participants 
EDE = evaporative dry eye. LLT = lipid layer thickness. MGD = meibomian gland dysfunction. 
20.2% (95%CI, 12.5-27.9); 21/104
27.9% (95%CI, 19.3-36.5); 29/104
6.7% (95%CI, 1.9-11.5); 7/104
2.9% (95%CI, -0.3-6.1); 3/104
29.8% (95%CI, 21.0-38.6); 31/104
5.8% (95%CI, 1.3-10.3); 6/104




































































































5.4.6 Relationship between dry eye sub-classification signs in dry eye 
participants 
Tear evaporation and TMH were significantly positive correlated with each other, as 
well as with MGD (Table 5.3). LLT did not significantly correlate with any other signs 
specific to ADDE or EDE (Table 5.3). 



















  -0.122 157 0.235** 157 0.171* 157 0.003 149 
LLT grade     0.028 162 -0.017 162 0.021 153 
TMH (mm)       0.065 162 0.197* 153 
Lower MGD (%)         0.133 153 
DED = dry eye disease. LLT = lipid layer thickness.TMH = tear meniscus height. MGD = meibomian gland 
dysfunction. * p-value ≤0.05. ** p-value ≤ 0.01. rs = spearman rank correlation coefficient. n = sample size.  
5.4.7 Relationship between dry eye sub-classification signs and symptoms in 
dry eye participants   
Within dry eye participants, higher DEQ-5 and OSDI scores were significantly 
associated to increased tear evaporation (Table 5.4). However, no other ADDE and 
EDE sign was significantly related to DED symptoms (Table 5.4). 
Table 5.4 Correlations between DED sub-classification signs and symptoms in DED participants 
 








 rS n rS n rS n rS n rS N 
DEQ-5 score 0.209** 157 -0.075 162 0.017 162 0.035 162 0.077 153 
OSDI score 0.178* 157 0.020 162 -0.017 162 0.046 162 0.132 153 
DED = dry eye disease. LLT = lipid layer thickness. TMH = tear meniscus height. MGD = meibomian gland 
dysfunction. DEQ-5 = 5-item Dry Eye Questionnaire. OSDI = Ocular Surface Disease Index. * p-value 




5.4.8 Risk factors of dry eye subtypes   
Age was significantly associated with EDE (Table 5.5). Sex, employment status, 
health conditions/problems, medication intake, sleep quality and outdoor activity did 
not result to be significant risk factors of either ADDE or EDE (Table 5.5). 
Table 5.5 Correlations between pure DED subtypes† and potential risk factors of DED 
 
Risk factors                                  Correlation with DED subtypes 
  rpb/ᵩ n  
Sex  -0.162 114  
Age  -0.270 114 ** 
Employment status  -0.172 112  
Health conditions/problems  -0.058 112  
Medication intake  0.051 112  
Sleep quality  -0.062 112  
Outdoor activity  0.137 111  
DED = dry eye disease. ADDE = aqueous deficient dry eye. EDE = evaporative dry eye. 
† EDE was coded as 1 and ADDE as 2. 
* p-value ≤0.05; ** p-value ≤0.01. 
rpb = point biserial correlation coefficient (used for age, sleep quality and outdoor activity). 
rᵩ = phi correlation coefficient (used for sex, employment status, health conditions/problems and 
medication intake). 
n = sample size. 
 
5.5 Discussion 
DED can be classified into ADDE and EDE, where the aqueous and lipid layer of the 
tear film are altered, respectively (Craig et al., 2017). Both DED subtypes can be 
confused as they present similar symptoms and general DED signs, however, their 
differential diagnosis is of utmost importance for making right decisions when treating 
and managing the disease (Jones et al., 2017).  
At present, the TFOS DEWS II globally recommends an initial DED diagnosis 
involving the assessment of ocular symptoms (using either the DEQ-5 or OSDI 
questionnaire) and signs (including the assessment of NIKBUT, tear hyperosmolarity 




adopt the recommended diagnostic criteria to further propose a sub-classification 
scheme of DED.  
The proposed sub-classification scheme was used to determine the prevalence and 
risk factors of ADDE and EDE among a single population of UK. It included the 
evaluation of the tear evaporation, TMH, LLT and upper/lower MGD described by 
meibomian gland dropouts. The diagnostic tests were also formerly suggested by the 
TFOS DEWS II for attempting DED classification (Wolffsohn et al., 2017); however, 
with no established diagnostic cut-off values.  
In the present study, tear evaporation, TMH, LLT and upper/lower MGD cut-off values 
were determined from clinical data of non-DED participants without health 
conditions/problems. Health conditions/problems were excluded as these 
significantly confounded normal tear film functions. Cut-off values producing the 
highest possible diagnostic specificities of the sub-classification tests were selected 
to allow greater confidence in the differential diagnosis of the disease (Wolffsohn et 
al., 2017). Accordingly, a TMH of <0.2 mm and LLT of grade ≥3, lower/upper MGD 
of ≤28% or tear evaporation rate of ≤46 g/m2/h were used to diagnose DED 
participants with ADDE. In contrast, EDE was diagnosed by a TMH of ≥0.2 mm and 
tear evaporation rate of >46 g/m2/h, LLT grade of <3, or lower/upper MGD of >29%.  
Interestingly, the TMH cut-off value used was consistent with that of Uchida et al. 
(Uchida et al., 2007). The cut-off values for tear evaporation, LLT and MGD were 
also in good agreement with previous studies associating tear evaporation rates of 
48.85 ± 23.47 g/m2/h (Tomlinson, Doane and McFadyen, 2009), LLT of ≥ 75 nm 
(Blackie et al., 2009), and meibomian gland dropouts of 30.1 ± 17.4% (Pult, 2018) to 




The study showed that EDE was the most common form of DED, with a prevalence 
rate of 64.2%. The findings were in accordance with previous research (Albietz, 2000; 
Rege et al., 2013; Asiedu, Dzasimatu and Kyei, 2018) and suggest that, in a major 
DED cohort, the lipid layer may be more compromised compared to the aqueous 
layer. Indeed, MGD was the most frequently occurring sub-classification sign, 
followed by increased tear evaporation, impaired LLT and reduced TMH.  
It should be noted that 17.3% DED participants had no obvious signs of ADDE and 
EDE. Unclassified DED has been observed in other studies attempting DED 
classification. Asiedu et al. reported 23.8% unclassified symptomatic DED 
participants and 25% unclassified asymptomatic DED participants (Asiedu, 
Dzasimatu and Kyei, 2018). Lemp et al. also were unable to categorise 29% of their 
study participants into evaporative, aqueous-deficient or mixed DED (Lemp et al., 
2012). Here, the disease might have been presented in the form of watery eyes (due 
to MGD) (Arita et al., 2015), misleading ADDE diagnosis. Moreover, because the tear 
film is variable over time, it might be possible that the lack of evidence of the sub-
classification signs was caused by stochastic or measurement noise. 
Importantly, the DED sub-classification scheme used was composed by essential 
sub-classification tests. Significant associations between tear evaporation, MGD and 
TMH underline their combined diagnostic contributions. Moreover, TMH, as the only 
ADDE sign, and LLT, as the most independent EDE sign, were indispensable to aim 
DED classification.  
Coexistence of both DED subtypes has been associated with increasing disease 
severity (Craig et al., 2017). A severity matrix was proposed by Bron et al. (Bron et 




elements of the matrix, DED severity has been rather assessed from the participants’ 
perspective by using symptom self-reports (Wolffsohn et al., 2017). Sullivan et al. 
described the disease severity as a continuum rather than distinct grades (Sullivan 
et al., 2010). This last approach is supported by poor associations between the sub-
classification tests and DED symptoms, as only tear evaporation and DED symptoms 
were significantly related to each other.  
Overall, the primary goal of DED treatment and management is to reconstruct the 
homeostasis of the tear film (Jones et al., 2017). Artificial tears of different 
compositions account the mainstay of DED therapy (Jones et al., 2017). Punctual 
plugging or tear stimulation, via topical medications, heating eyebags or essential 
fatty acid supplementation, are also of growing interest (Jones et al., 2017). Other 
treatment options focus on lid hygiene or avoiding DED risk factors (Jones et al., 
2017). One study has shown that DED sub-classification can help to identify 
effectiveness of different artificial tears formulations in individuals with DED (Essaa, 
2015). Future studies are needed to test other products using the new sub-
classification scheme developed in this study.  
Several large-scale population-based studies have associated DED to different risk 
factors (Stapleton et al., 2017), but not specifically to DED subtypes. In the present 
study, EDE was found to be significantly related to age, whereas ADDE had no 
significant risk factors. The association between EDE and aging can be attributed by 
functional and structural changes of meibomian glands occurring with increasing age 
(Sharma and Hindman, 2014).  
In conclusion, the study has demonstrated that EDE, as characterized by signs of 




residents. Moreover, age is a significant risk factor of EDE. Further research, applying 
the proposed sub-classification scheme in different populations, is of interest for 





6. CHAPTER 6: IMPROVING DRY EYE EPIDEMIOLOGICAL RESEARCH 
6.1 Overview 
The present chapter is a collaborative study between Aston University (Birmingham, 
UK) and the University of Auckland (Auckland, New Zealand) (Wolffsohn et al., 2018). 
It discusses a cost-effective diagnostic method for DED by ocular symptoms and 
signs. 
6.2 Introduction 
Different epidemiological study designs exist to investigate the burden of DED and 
subsequently plan and allocate health sources (Mann, 2003; Stapleton et al., 2017). 
The study designs are divided into experimental and observational and can be further 
sub-categorised as cross-sectional studies, case-control studies, and cohort studies 
(Mann, 2003).  
Observational cross-sectional studies are the most commonly used approach in the 
epidemiology of DED, whereby the disease prevalence and risk factors are evaluated 
at one point in time (Stapleton et al., 2017). However, common inferences are difficult 
to make since the studies have relied on different disease diagnoses (Stapleton et 
al., 2017).  
In view to standardization, the TFOS DEWS II recommended a global diagnosis of 
the disease (Wolffsohn et al., 2017). This identifies an individual as having DED by a 
positive result to a validated questionnaire (either the DEQ-5 or OSDI test) and the 
presence of one ocular sign (determined either by assessing the NIKBUT, tear 




The TFOS DEWS II criteria has unfortunately not been used in large-scale population 
studies yet. Cost and limited accessibility of the required clinical instrumentation 
might have been a barrier to its use. In fact, researchers’ tendency is often to move 
away from high-cost diagnostic techniques towards economical diagnoses of DED 
that are commercially available in all parts of the world (Savini et al., 2008).  
Recently, the OptrexTM dry eye blink test has been advertised as a free rapid self-
administered online test that indicates whether an individual might suffer from DED. 
Like the NIKBUT, it assesses the stability of the tear film, but based on the time that 
takes for the eyes to sense ocular discomfort when staring up to 15 seconds at a 
digital screen and without blinking.  
The present study is the first to validate the diagnostic ability of the OptrexTM dry eye 
blink test. The study aim was to propose a cost-effective DED diagnostic method, 
involving the DEQ-5, OSDI and OptrexTM dry eye blink test, that conforms to the 
TFOS DEWS II criteria and is cost-effective for DED epidemiological research. 
6.3 Methodology 
The study was performed in accordance with the principles of the Declaration of 
Helsinki and approved by the institutional ethics committees of Aston University 
(Birmingham, UK) and University of Auckland (Auckland, New Zealand).  
Study participants were recruited from both centres and enrolled after written consent 
inform. Participants were excluded if they had any active ocular diseases or were 
currently using ocular medications. The exclusion criteria did not include any further 
risk factors of DED as the study intended to involve participants of different DED 




All investigators received substantial clinical training prior to the study. Ocular 
symptoms were gathered using both DEQ-5 and OSDI questionnaires. In the 
following order, tear osmolarity, NIKBUT, the OptrexTM dry eye blink test and ocular 
surface staining (including the cornea, conjunctiva and upper/lower LWE) were 
assessed on participants’ right eye. 
Clinical assessment was conducted as described in Chapter 2. However, subjective 
methods, including two four-point grading scale (Korb et al., 2005; Whitcher et al., 
2010) (Table 6.1), were used to score ocular surface staining. The rationale behind 
this amendment was to ease the clinical study performance between both sites.  
Table 6.1 Ocular surface grading scales used 
 
Ocular surface  Grading scores 
Corneal/conjunctival  
(Whitcher et al., 2010) 
score 0: 0-9 staining dots 
score 1: 10-32 staining dots 
score 2:  33-100 staining dots 
score 3: >100 staining dots 
LWE staining 
(Korb et al., 2005) 
score 0: <2 mm long and 25% wide staining 
score 1: 2 – 4 mm long and 25 – 49% wide staining 
score 2: 5 – 9 mm long and 50 – 74 % wide staining 
score 3: > 10 mm long and ≥ 75% wide staining 
LWE = lid wiper epitheliopathy.  
 
The OptrexTM dry eye blink test was displayed on a 14-inch computer monitor 
(LenovoTM ThinkPad® T470p) at approximately 40 cm (Figure 6.1). The gaze angle 





Figure 6.1 The OptrexTM dry eye blink test (reproduced with permission of Reckitt Benckiser) 
 
Study participants were asked to deliver two non-force blinks and hold their blinking 
after having started the OptrexTM dry eye blink test. Testing with the OptrexTM dry eye 
blink test ended either after 15 seconds or when ocular discomfort was felt. Three 
consecutive measurements were taken, and the mean was recorded.  
NIKBUT and OptrexTM dry eye blink test readings were compared to understand the 
level of interchangeability of both tear film stability measurements. Also, correlations 
of DED signs and symptoms with the OptrexTM dry eye blink test were examined. 
DED was defined by the TFOS DEWS II criteria (Wolffsohn et al., 2017), more 
specifically, by a DEQ-5 score of ≥6 or OSDI score of ≥13 and either one of the 
following:  
 A NIKBUT of <10s, 
 A tear film osmolarity of ≥308 mOsm/l or an intraocular osmolarity difference of 




 Ocular surface staining described by >5 corneal spots, >9 conjunctival spots or 
the presence of LWE at the inner eyelid margin (≥25% wide and ≥2mm long).  
The diagnostic performance of the OptrexTM dry eye blink test was examined against 
the TFOS DEWS II criteria. An OptrexTM dry eye blink test cut-off score was 
subsequently determined. The cut-off value was adopted together with a DEQ-5 
score of ≥6 or OSDI score of ≥13 to further define DED by ocular symptoms and signs 
following TFOS DEWS II diagnostic recommendations.  
6.3.1 Power calculation 
The required sample size of eighty-five participants was calculated using following 
formula: n = [(Zα + Zβ)/(0.5xln[(1+r)/(1-r)]]2 +3, where n was the sample size, α the 
rate of false positives of DED, Zα the standard deviation of α, β the rate of false 
negatives of DED, Zβ the standard deviation of β and r the correlation coefficient 
(Hulley et al., 2013). The sample size was determined to seek a sizeable correlation 
coefficient of at least 0.30 between the OptrexTM dry eye blink test and NIKBUT 
(Jacob Cohen, 1992). Conventional values of α and β were used (α, 0.05; β, 0.20) 
(Hulley et al., 2013).  
6.3.2 Data processing  
Because of the OptrexTM dry eye blink test having a maximum duration of 15s, 
NIKBUT readings of >15s were capped into values of 15s. Moreover, for statistical 
purposes, both OptrexTM dry eye blink test and NIKBUT readings underwent 




6.3.3 Statistical analysis 
Statistical analysis was performed using SPSS version 23 (IBM Corp. 2015). Except 
for tear film stability measurements, DED symptoms and signs were found to be not 
normally distributed using Kolmogorov-Smirnov tests.  
Measurements of OptrexTM dry eye blink test and NIKBUT were compared using 
paired t and F tests. Correlations of DED signs and symptoms with the OptrexTM dry 
eye blink test were evaluated with Spearman correlation coefficients. For NIKBUT 
though, Pearson correlation coefficients were used.  
A receiver operative characteristics (ROC) curve of the OptrexTM dry eye blink test 
was illustrated. The ROC curve was constructed by plotting the rate of true positives 
against the rate of false positives of DED by the TFOS DEWS II criteria for every 
possible OptrexTM dry eye blink test value. The area under the ROC curve determined 
the diagnostic ability of the OptrexTM dry eye blink test. Younden’s J indexes 
(computed as 𝐽𝐽 =  𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑡𝑡𝑝𝑝𝑝𝑝𝑡𝑡𝑝𝑝
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑡𝑡𝑝𝑝𝑝𝑝𝑡𝑡𝑝𝑝 +𝑓𝑓𝑓𝑓𝑓𝑓𝑝𝑝𝑡𝑡 𝑛𝑛𝑡𝑡𝑛𝑛𝑓𝑓𝑡𝑡𝑝𝑝𝑝𝑝𝑡𝑡𝑝𝑝
+  𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑛𝑛𝑡𝑡𝑛𝑛𝑓𝑓𝑡𝑡𝑝𝑝𝑝𝑝𝑡𝑡𝑝𝑝
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑛𝑛𝑡𝑡𝑛𝑛𝑓𝑓𝑡𝑡𝑝𝑝𝑝𝑝𝑡𝑡𝑝𝑝 +𝑓𝑓𝑓𝑓𝑓𝑓𝑝𝑝𝑡𝑡 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑡𝑡𝑝𝑝𝑝𝑝𝑡𝑡𝑝𝑝
− 1 =
𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑣𝑣𝑠𝑠𝑠𝑠𝑣𝑣 + 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑣𝑣 − 1) were calculated for all OptrexTM dry eye blink test 
values. The OptrexTM dry eye blink test value with the greatest Younden’s J index 
(and hence with maximal diagnostic sensitivity and specificity) was defined as the 
cut-off score.  
Finally, both diagnostic sensitivity and specificity of the proposed DED diagnostic 
method involving the OptrexTM dry eye blink test and DEQ-5 or OSDI questionnaire 





Eighty-seven participants (38 ± 17 years, 44 females) were included in the present 
study (Table 6.2). Of these, 71% fulfilled the TFOS DEWS II diagnostic criteria of 
DED.   
Table 6.2 Tear film and ocular surface characteristics of the study participants 
 
Characteristics n mean ± SD/ median (range) 
DEQ-5 score 87 8.72 ± 4.46 
OSDI score 87 19.19 ± 15.85 
Highest tear film osmolarity value (mOsm/l) 87 305.08 ± 13.57 
Interocular osmolarity difference (mOsm/l) 87 8.71 ± 7.40 
NIKBUT (s) 87 9.52 ± 7.33 
OptrexTM dry eye blink test (s) 87 9.83 ± 3.95 
Corneal staining score 87 0 (0-1) 
Conjunctival staining score 87 0 (0-1) 
Upper LWE score 87 0 (0-0) 
Lower LWE score 87 0 (0-2) 
DEQ-5 = 5-item Dry Eye Questionnaire, OSDI = Ocular Surface Disease Index. NIKBUT = non-invasive 
Keratograph tear break-up time. LWE = lid wiper epitheliopathy. n = sample size. SD = standard 
deviation. 
 
Measurements of the OptrexTM dry eye blink test and NIKBUT were not significantly 
different (p-value, 0.150). Nevertheless, the OptrexTM dry eye blink test showed a 
significantly narrower distribution compared to that of the NIKBUT (p-value, <0.001).  
Among all DED parameters, significant correlations with the OptrexTM dry eye blink 
test were observed with OSDI, DEQ-5, NIKBUT, conjunctival staining and lower LWE 
(Table 6.3). 
Table 6.3 Correlations of DED symptoms and signs with the OptrexTM dry eye blink test 
 
 Correlation with the OptrexTM dry eye blink test 
Characteristics n Correlation coefficient p-value 
DEQ-5 score 87 -0.364 0.004** 
OSDI score 87 -0.290 0.006** 
Highest tear film osmolarity value (mOsm/L) 87 -0.066 0.55 
Interocular osmolarity difference (mOsm/L) 87 -0.010 0.93 
NIKBUT (s) 87 0.470 0.001*** 
Corneal staining score 87 -0.163 0.13 
Conjunctival staining score 87 -0.237 0.03* 
Upper LWE score 87 0.018 0.87 
Lower LWE score 87 -0.251 0.02* 
DEQ-5 = 5-item Dry Eye Questionnaire. OSDI = Ocular Surface Disease Index. NIKBUT = non-invasive 
Keratograph tear break-up time. LWE = lid wiper epitheliopathy. n = sample size. SD = standard 




The diagnostic ability of the OptrexTM dry eye blink test was significant moderately 
strong (p-value, <0.001), showing an area under the ROC curve of 0.77 (Figure 6.2). 
 
Figure 6.2 ROC curve assessing the diagnostic ability of the OptrexTM dry eye blink test  
 
The greatest Younden’s J index of 0.54 was found with an OptrexTM dry eye blink test 
value of ≤10s. The OptrexTM dry eye blink test value presented a sensitivity of 66% 
and specificity of 88%. 
DED diagnosis by an OptrexTM dry eye blink test of ≤10 s and either by DEQ-5 score 
of ≥6 or OSDI score of ≥13 presented a diagnostic sensitivity and specificity of 100% 
and 54%, respectively (Table 6.4).  
Table 6.4 DED outcomes by the proposed DED diagnostic method and the TFOS DEWS II  
criteria 
 
DED outcomes of the proposed diagnostic 
method 
DED outcomes of the TFOS DEWS II criteria 
Negative  Positive Total 
Negative 25 21 46 
Positive 0 41 41 




























Researchers take specially care in balancing the costs and diagnostic accuracy of 
clinical tests for DED (Savini et al., 2008). In the present study, a rapid online test 
assessing tear film stability (the OptrexTM dry eye blink) was validated to further 
propose a DED diagnostic method by ocular symptoms and signs. The proposed 
method involved the use of the DEQ-5, OSDI and OptrexTM dry eye blink test. It 
should serve as a simple self-administered DED diagnostic method that conforms to 
the TFOS DEWS II criteria (Wolffsohn et al., 2017) and is cost-effective for DED 
epidemiological research.  
The results showed that NIKBUT and OptrexTM dry eye blink test readings were 
similar, enforcing the idea that the OptrexTM dry eye blink test constitutes a feasible 
alternative method for assessing tear film stability. It is important to note, however, 
that the OptrexTM dry eye blink test had a significantly narrower distribution than the 
NIKBUT, even when NIKBUT values were capped at 15s (Wolffsohn et al., 2018). 
Hence, beyond this point, the disagreement between both tests would probably 
increase (Wolffsohn et al., 2018). 
As expected, a significant positive correlation between the NIKBUT and Optrex’s dry 
eye blink test was observed. It is believed that any tear disruption results in a transient 
and localised tear osmolarity increase that stimulates nociceptors responsible for 
driving the blink reflex to replenish the tear film (Varikooty and Simpson, 2009). If tear 
disruptions account as well as a direct trigger to ocular discomfort, it would be 
expected that the correlation between the NIKBUT and OptrexTM dry eye blink test 
would have been greater than moderate (Wolffsohn et al., 2018). Accordingly, the 
results suggest that symptom self-report might have been influenced by patients’ high 




Higher OptrexTM dry eye blink test readings were also significantly associated with 
decreasing ocular symptoms, either assessed by the DEQ-5 or OSDI, conjunctival 
staining and lower LWE staining. The associations are supported by current literature 
(Yeniad, Beginoglu and Bilgin, 2010; Zhang et al., 2017). Other DED signs showed 
similarly negative trends with higher OptrexTM dry eye blink test readings but without 
statistical significance. 
Generally, the diagnostic ability of a test can be described by its sensitivity and 
specificity (Lalkhen and McCluskey, 2008). The sensitivity and specificity are 
measures that describe how well a test correctly identified those with and without a 
disease, respectively (Lalkhen and McCluskey, 2008). A trade-off typically exists 
between the two measures with the precise values for each selected cut-off value for 
a positive diagnosis (Lalkhen and McCluskey, 2008). In the present study, the 
OptrexTM dry eye blink test showed a significant moderately strong diagnostic ability 
when performed against the TFOS DEWS II criteria. The diagnostic ability was given 
graphically by the area under the ROC curve of 0.77, showing a maximal sensitivity 
of 66% and specificity of 88% for an OptrexTM dry eye blink test cut-off value of ≤10s. 
The cut-off value was similar to the NIBUT cut-off value reported by the TFOS DEWS 
II (Wolffsohn et al., 2018). 
Because the last updated definition of DED describes the disease by a combination 
of symptoms and signs (Craig et al., 2017), the OptrexTM dry eye blink test of ≤10s 
on its own can only be considered as an indicative diagnostic method for DED. 
Interestingly, DED diagnosis by an OSDI score of ≥13 or DEQ-5 score of ≥6 and 
OptrexTM dry eye blink test of ≤10s was 100% sensitive and 54% specific to the TFOS 
DEWS II. The approach may be used as a screening tool as it is rapid and simple to 




In conclusion, the OptrexTM dry eye blink test combined with symptoms self-reports 
could work as a cost-effective diagnostic method for DED, especially for future 
epidemiological DED research. The OptrexTM dry eye blink test cut-off value used 






7. CHAPTER 7: DISCUSSION AND CONCLUSIONS 
The epidemiology of DED aims to answer basic research questions – How many 
people are affected by the disease? Which are the risk factors for the disease?  Which 
are the care health sources needed? These questions, however, encompass 
enormous methodological and interpretive complexity.  
Researchers have assessed DED prevalence and risk factors differently, using a 
range of disease diagnoses and risk factor assessments. The inconsistencies across 
published cross-sectional studies have created barriers to interpreting the results. 
Moreover, the heterogeneity in the characteristics of the population studied has 
further complicated the research.  
A thorough evaluation of existing differences in epidemiological research on DED is 
essential. In providing such information, researchers would gain a better 
understanding on DED epidemiology and identify research gaps that need to be filled 
for future research improvement.  
This thesis initially includes a literature review of current DED prevalence rates and 
risk factors (Chapter 1). It extracted information of cross-sectional studies that have 
been published since the last decade, emphasizing on the DED diagnostic methods 
used, the characteristics of the population studied and logistic regression analyses 
of DED risk factors. 
Given the limitations of the current state of epidemiological literature on DED, the 
overarching goal of this thesis was to perform a well-standardized DED cross-
sectional study. Accordingly, a study methodology following global Tear Film Ocular 




disease published in 2017 was considered (Chapter 2). This should ensure 
comparability with future reports.  
Prevalence rates of DED (Chapter 3) and DED subtypes (Chapter 5) were estimated 
among a single population in the UK. Potential risk factors of DED (Chapter 4) and 
DED subtypes (Chapter 5) were also assessed using a self-administered evidence-
based dry eye risk factor survey (DERFS). Lastly, a simple, cost-effective and self-
administered DED diagnostic criteria by the TFOS DEWS II diagnostic criteria was 
developed (Chapter 2). 
A summary of the main findings of this thesis by chapter is detailed below: 
• Chapter 1. This chapter reviewed prevalence rates and risk factors reported in 
recent epidemiological studies of DED. The prevalence of DED was found to 
range from 1.3% to 52.9%. Identified risk factors for DED were either modifiable 
or non-modifiable and included age, sex, health conditions/problems, ambient 
conditions, contact lens wear, VDT use, diet and sleep duration. The chapter 
highlighted that the reported prevalence rates and risk factors of the disease 
varied with the diagnostic methods used and the characteristics of the population 
studied. DED diagnosis was based either on the WHS criteria, symptoms, signs 
or both symptoms and signs. Asians were the most commonly studied population 
in the epidemiology of the disease.  
 
• Chapter 2. Having noted the influence of the diagnostic methodology on the 
disease prevalence and risk factors (Chapter 1), the next key aspect was to 
optimise this based on the current consensus around diagnosis, but also to 




questionnaire as no suitable ‘validated’ form currently existed. Hence Chapter 2 
included a broad summary of the study methodology used for this thesis. DED 
questionnaires, including the OSDI and DEQ-5, and measurements of tear 
osmolarity, tear evaporation, LLT, TMH, NIKBUT, ocular surface staining and 
MGD were considered. The use of these tests for the initial and differential 
diagnosis of DED is supported by previous clinical research. According to the 
TFOS DEWS II, they account together the most efficient battery to diagnose DED 
as per the last updated disease definition and classification. Moreover, the 
DERFS questionnaire was used to assess potential risk factors for DED. The 
survey was developed based on current evidence on DED risk factors discussed 
in Chapter 1. 
 
• Chapter 3. Having clarified the appropriate methodology for studying DED 
epidemiological estimates and developed the DERFS (Chapter 2), an ethical 
opinion and governance procedure for the study was sought and granted allowing 
a cross-sectional study to commence. As such, Chapter 3 determined the 
prevalence of DED at a single point in time. The diagnostic criteria used was the 
TFOS DEWS II criteria. The study population included female and male 
Birmingham (UK) residents aged 18 to 88 years-old. These were stratified in 
recruitments so that they were representative to the Birmingham population 
census of 2016. The prevalence of DED varied with the diagnostic method used, 
ranging from to 19.0% to 56.3%, and was significantly higher where ocular 
surface staining was assessed. Moreover, ocular symptoms were significantly 
more prevalent with the DEQ-5 than with the OSDI test. Notably, the study was 
the first in estimating the prevalence of DED by the TFOS DEWS II criteria. The 




diagnostic method based on DED symptoms and tear film instability appeared 
the most suitable method for the disease. 
 
• Chapter 4. Having assessed the prevalence of DED population by the TFOS 
DEWS II criteria, DED and non-DED participants were identified to allow risk 
factors to be assessed from the DERFS. Female sex, age, employment status, 
the presence of any health conditions/problems, medication intake, poor sleep 
quality and prolonged outdoor activity were found to be significant risk factors of 
DED. Amongst these, female sex, the presence of any health 
conditions/problems, poor sleep quality and prolonged outdoor activity had the 
greatest statistical significance. The results were in accordance with other studies 
reporting risk factors of DED by either the WHS criteria, symptoms, signs or 
symptoms and signs. 
 
• Chapter 5. DED is sub-classified as having ADDE and EDE forms. The forms are 
intended to inform management decisions and hence are important to be clinically 
distinguished. Unfortunately, a review of the literature acknowledged no apparent 
consistency in the sub-classification of DED. To this purpose, Chapter 5 proposed 
a differential diagnosis of ADDE and EDE. The differential diagnosis was in line 
with current TFOS DEWS II diagnostic recommendations. DED and non-DED 
participants were identified in Chapter 3. ADDE was characterized by a reduction 
in TMH; conversely, EDE was defined by signs of LLT, tear evaporation and 
MGD. Diagnostic cut-off values of the sub-classification tests, that were as 
specific as possible in discriminating ADDE and EDE, were determined from 
clinical data of healthy non-DED participants. Whereas older DED participants 




Prevalence rates of 6.2% for ADDE, 64.2% for EDE and 11.1% for both ADDE 
and EDE were estimated. This was in accordance with previous research 
reporting EDE as the more common form of DED. The approach taken will allow 
clinicians to make a more informed choice for an initial DED management for 
individual patients, although further research is needed to warrant advocating 
this. 
 
• Chapter 6. So far, the chapters involved complex clinical testing which is not 
available to many eye care practitioners and other health care professionals, such 
as pharmacists and general medical practitioners, who are often approached by 
patients about DED symptoms and need to be able to make an informed 
differential diagnosis. Chapter 6 proposed a self-administered diagnostic method 
for DED that conformed to the TFOS DEWS II criteria. DED was diagnosed by 
an OSDI score of ≥13 or DEQ-5 score of ≥6 and OptrexTM dry eye blink test of 
≤10s. This last test assessed the tear film stability based on the time that takes 
for the eyes to sense ocular discomfort. The proposed DED diagnosis was found 
to be 100% sensitive and 54% specific to the TFOS DEWS II diagnostic criteria. 
The diagnostic method should help patients in empowering their self-
management of symptoms with the caveat that, if these persist, a full examination 
with a suitably equipped and skilled eye-care professional should be sought. 
Moreover, the diagnostic method could be used for DED epidemiological 
research, as it is rapid and cost-effective and hence reduces both cost and time 




As the first of its kind, this thesis serves as an insight into prevalence and risk factors 
of DED and DED subtypes of a single population in the UK, following current global 
diagnostic recommendations of the TFOS DEW II. 
Clinicians should be aware that ocular surface staining is a common sign that does 
not necessarily translate into DED. DED by symptoms and ocular surface staining 
should be carefully distinguished with other ocular conditions involving symptoms and 
ocular hyperaemia. On the other hand, in the absence of a complete test battery for 
DED (as recommended by the TFOS DEWS II), the assessment of tear film stability 
and symptoms may be suitable on its own to diagnose the disease. The OptrexTM dry 
eye blink test may be used for this purpose.   
The main limitations of this thesis are intrinsic to the study design. The association 
and certainty of the obtained cross-sectional risk factors of DED and DED subtypes 
would be stronger in a longitudinal study. The sample size calculation might be limited 
as it was based on a British female cohort; however, this cohort was the only available 
UK data that could be referred to at the time of the thesis. The prevalence and risk 
factors of DED and DED subtypes obtained were also specific to the Birmingham, 
UK population. 
In view to future directions in DED research, the author has collected equivalent data 
in Valencia, Spain. The developed protocol was also facilitated to other colleagues 
of the European Dry Eye Network (EDEN) and researchers based in New Zealand, 
China and Mexico to further allow similar data collection and hence future reliable 






Abusharha, A. A. and Pearce, E. I. (2013) ‘The effect of low humidity on the human 
tear film’, Cornea. doi: 10.1097/ICO.0b013e31826671ab. 
Abusharha, A. A., Pearce, E. I. and Fagehi, R. (2016) ‘Effect of Ambient Temperature 
on the Human Tear Film’, Eye and Contact Lens. doi: 
10.1097/ICL.0000000000000210. 
Ahn, J. M. et al. (2014) ‘Prevalence of and risk factors associated with dry eye: The 
Korea National Health and Nutrition Examination Survey 2010-2011’, American 
Journal of Ophthalmology. doi: 10.1016/j.ajo.2014.08.021. 
Albietz, J. M. (2000) ‘Prevalence of dry eye subtypes in clinical optometry practice’, 
Optometry and Vision Science. doi: 10.1097/00006324-200007000-00010. 
Argilés, M. et al. (2015) ‘Blink rate and incomplete blinks in six different controlled 
hard-copy and electronic reading conditions’, Investigative Ophthalmology and Visual 
Science. doi: 10.1167/iovs.15-16967. 
Arita, R. et al. (2008) ‘Noncontact Infrared Meibography to Document Age-Related 
Changes of the Meibomian Glands in a Normal Population’, Ophthalmology. doi: 
10.1016/j.ophtha.2007.06.031. 
Arita, R. et al. (2015) ‘Increased tear fluid production as a compensatory response to 
meibomian gland loss: A multicenter cross-sectional study’, Ophthalmology. doi: 
10.1016/j.ophtha.2014.12.018. 
Arya, R., Antonisamy, B. and Kumar, S. (2012) ‘Sample size estimation in prevalence 
studies’, Indian Journal of Pediatrics. doi: 10.1007/s12098-012-0763-3. 
Asiedu, K., Dzasimatu, S. K. and Kyei, S. (2018) ‘Clinical subtypes of dry eye in 
youthful clinical sample in Ghana’, Contact Lens and Anterior Eye. doi: 
10.1016/j.clae.2018.10.005. 
Ayaki, M. et al. (2016) ‘Sleep and mood disorders in dry eye disease and allied 
irritating ocular diseases’, Scientific Reports. doi: 10.1038/srep22480. 
Baudouin, C. et al. (2010) ‘Preservatives in eyedrops: The good, the bad and the 
ugly’, Progress in Retinal and Eye Research. doi: 10.1016/j.preteyeres.2010.03.001. 
Belmonte, C. et al. (2017) ‘TFOS DEWS II Pain and sensation report’, Ocular 
Surface. doi: 10.1016/j.jtos.2017.05.002. 
Belmonte, C., Acosta, M. C. and Gallar, J. (2004) ‘Neural basis of sensation in intact 
and injured corneas’, Experimental Eye Research. doi: 10.1016/j.exer.2003.09.023. 
Bhargava, R. et al. (2015) ‘Oral omega-3 fatty acids treatment in computer vision 





Blackie, C. A. et al. (2009) ‘The Relationship Between Dry Eye Symptoms and Lipid 
Layer Thickness’, Cornea. doi: 10.1097/ico.0b013e318191b870. 
Bron, A. J. et al. (2002) ‘Using osmolarity to diagnose dry eye: a compartmental 
hypothesis and review of our assumptions’, in Advances in Experimental Medicine 
and Biology, pp. 1087–95. 
Bron, A. J. et al. (2004) ‘Functional aspects of the tear film lipid layer’, Experimental 
Eye Research. doi: 10.1016/j.exer.2003.09.019. 
Bron, A. J. et al. (2007) ‘Methodologies to Diagnose and Monitor Dry Eye Disease’, 
The Ocular Surface. doi: 10.1590/S0004-27492011000500016. 
Bron, A. J. et al. (2014) ‘Rethinking dry eye disease: a perspective on clinical 
implications’, The Ocular Surface, 12 (2S), pp. S1-31. 
Browner, W. S. and Newman, T. B. (1986) ‘Confidence intervals.’, Annals of internal 
medicine. 
Calonge, M. et al. (2018) ‘Controlled Adverse Environment Chambers in Dry Eye 
Research’, Current Eye Research. doi: 10.1080/02713683.2017.1420197. 
Chalmers, R. L., Begley, C. G. and Caffery, B. (2010) ‘Validation of the 5-Item Dry 
Eye Questionnaire (DEQ-5): Discrimination across self-assessed severity and 
aqueous tear deficient dry eye diagnoses’, Contact Lens and Anterior Eye. doi: 
10.1016/j.clae.2009.12.010. 
Chen, Q. et al. (2017) ‘Effects of tear film lipid layer thickness and blinking pattern on 
tear film instability after corneal refractive surgery’, Cornea. doi: 
10.1097/ICO.0000000000001207. 
Chu, C. A., Rosenfield, M. and Portello, J. K. (2014) ‘Blink patterns: Reading from a 
computer screen versus hard copy’, Optometry and Vision Science. doi: 
10.1097/OPX.0000000000000157. 
Craig, J. P. et al. (2017) ‘TFOS DEWS II Definition and Classification Report’, Ocular 
Surface. doi: 10.1016/j.jtos.2017.05.008. 
Craig, J. P. and Tomlinson, A. (1997) ‘Importance of the lipid layer in human tear film 
stability and evaporation’, Optometry and Vision Science. doi: 10.1097/00006324-
199701000-00014. 
Daniel Nelson, J. et al. (2011) ‘The international workshop on meibomian gland 
dysfunction: Report of the definition and classification subcommittee’, Investigative 
Ophthalmology and Visual Science. doi: 10.1167/iovs.10-6997b. 
DasGupta, A., Cai, T. T. and Brown, L. D. (2001) ‘Interval Estimation for a Binomial 
Proportion’, Statistical Science. doi: 10.1214/ss/1009213286. 
Doane, M. G. (1994) ‘Abnormalities of the Structure of the Superficial Lipid Layer on 
the in Vivo Dry-Eye Tear Film.’, in Sullivan D.A. (ed.) Lacrimal Gland, Tear Film, and 




Doughty, M. J. et al. (2004) ‘Visualisation of “Marx’s line” along the marginal eyelid 
conjunctiva of human subjects with lissamine green dye’, Ophthalmic and 
Physiological Optics. doi: 10.1046/j.1475-1313.2003.00160.x. 
Drouault-Holowacz, S. et al. (2009) ‘Antioxidants intake and dry eye syndrome: A 
crossover, placebo-controlled, randomized trial’, European Journal of 
Ophthalmology. 
Efron, N. et al. (2013) ‘The TFOS International Workshop on Contact Lens 
Discomfort: Report of the contact lens interactions with the ocular surface and adnexa 
subcommittee’, Investigative Ophthalmology and Visual Science. doi: 
10.1167/iovs.13-13187. 
Efron, N. et al. (2016) ‘Lid wiper epitheliopathy’, Progress in Retinal and Eye 
Research. doi: 10.1016/j.preteyeres.2016.04.004. 
Essaa, L. (2015) What is the optimum artificial treatment for dry eye disease? 
Feenstra, R. P. G. and Tseng, S. C. G. (1992) ‘Comparison of Fluorescein and Rose 
Bengal Staining’, Ophthalmology. doi: 10.1016/S0161-6420(92)31947-5. 
Finis, D. et al. (2015) ‘Evaluation of Meibomian Gland Dysfunction and Local 
Distribution of Meibomian Gland Atrophy by Non-contact Infrared Meibography’, 
Current Eye Research. doi: 10.3109/02713683.2014.971929. 
Galor, A. et al. (2015) ‘Dry eye symptoms align more closely to non-ocular conditions 
than to tear film parameters’, British Journal of Ophthalmology. doi: 
10.1136/bjophthalmol-2014-306481. 
Galor, A. et al. (2018) ‘The Association of Dry Eye Symptom Severity and Comorbid 
Insomnia in US Veterans’, Eye & contact lens. doi: 10.1097/ICL.0000000000000349. 
Gatell-Tortajada, J. (2016) ‘Oral supplementation with a nutraceutical formulation 
containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series 
of patients with dry eye symptoms: Results of a prospective study’, Clinical 
Interventions in Aging. doi: 10.2147/CIA.S98102. 
Gokhale, M., Stahl, U. and Jalbert, I. (2013) ‘In situ osmometry: Validation and effect 
of sample collection technique’, Optometry and Vision Science. doi: 
10.1097/OPX.0b013e31828aaf10. 
González-García, M. J. et al. (2007) ‘Exposure to a controlled adverse environment 
impairs the ocular surface of subjects with minimally symptomatic dry eye’, 
Investigative Ophthalmology and Visual Science. doi: 10.1167/iovs.06-0817. 
Gothwal, V. K. et al. (2010) ‘McMonnies questionnaire: Enhancing screening for dry 
eye syndromes with rasch analysis’, Investigative Ophthalmology and Visual 
Science. doi: 10.1167/iovs.09-4180. 
Goto, E. et al. (2003) ‘Computer-Synthesis of an Interference Color Chart of Human 
Tear Lipid Layer, by a Colorimetric Approach’, Investigative Ophthalmology and 




Gowrisankaran, S. and Sheedy, J. E. (2015) ‘Computer vision syndrome: A review’, 
Work. doi: 10.3233/WOR-152162. 
Gowrisankaran, S., Sheedy, J. E. and Hayes, J. R. (2007) ‘Eyelid squint response to 
asthenopia-inducing conditions’, Optometry and Vision Science. doi: 
10.1097/OPX.0b013e3180dc99be. 
Green-Church, K. B. et al. (2011) ‘The international workshop on meibomian gland 
dysfunction: Report of the subcommittee on tear film lipids and lipid-protein 
interactions in health and disease’, Investigative Ophthalmology and Visual Science. 
doi: 10.1167/iovs.10-6997d. 
Guillemin, I. et al. (2012) ‘Appraisal of patient-reported outcome instruments available 
for randomized clinical trials in dry eye: Revisiting the standards’, Ocular Surface. 
doi: 10.1016/j.jtos.2012.01.007. 
Guillon, J. P. (1982) ‘Tear film photography and contact lens wear’, Journal of the 
British Contact Lens Association. doi: 10.1016/S0141-7037(82)80022-0. 
Guillon, J. P. (1998) ‘Non-invasive tearscope plus routine for contact lens fitting’, 
Contact Lens and Anterior Eye. doi: 10.1016/S1367-0484(98)80035-0. 
Guo, B. et al. (2010) ‘Prevalence of dry eye disease in Mongolians at high altitude in 
China: The Henan eye study’, Ophthalmic Epidemiology. doi: 
10.3109/09286586.2010.498659. 
Hamrah, P. et al. (2011) ‘Optimizing evaluation of Lissamine Green parameters for 
ocular surface staining’, Eye. doi: 10.1038/eye.2011.184. 
Han, S. B. et al. (2011) ‘Prevalence of dry eye disease in an elderly Korean 
population’, Archives of Ophthalmology. doi: 10.1001/archophthalmol.2011.78. 
Hashemi, H. et al. (2014) ‘Prevalence of dry eye syndrome in an adult population’, 
Clinical and Experimental Ophthalmology. doi: 10.1111/ceo.12183. 
Himebaugh, N. L. (2009) ‘Blinking and tear break-up during four visual tasks’, 
Optometry and Vision Science. doi: 10.1097/OPX.0b013e318194e962. 
Holly, F. J. (1985) ‘Physical chemistry of the normal and disordered tear film.’, 
Transactions of the ophthalmological societies of the United Kingdom. 
Holly, F. J. and Lemp, M. A. (1977) ‘Tear physiology and dry eyes’, Survey of 
Ophthalmology. doi: 10.1016/0039-6257(77)90087-X. 
Hulley, S. B. et al. (2013) Designing clinical research : an epidemiologic approach. 
4th ed. Philadelphia, PA: Lippincott Williams & Wilkins, Optometry Vision Science. 
doi: 10.1097/00006982-199010000-00024. 
Hwang, H. Bin and Kim, H. S. (2014) ‘Phototoxic effects of an operating microscope 
on the ocular surface and tear film’, Cornea. doi: 10.1097/ICO.0000000000000001. 




outdoor air pollution and dry eye disease in South Korea’, JAMA Ophthalmology. doi: 
10.1001/jamaophthalmol.2016.0139. 
Ipek, T. et al. (2018) ‘Dry eye following cataract surgery: The effect of light exposure 
using an in-vitro model’, Contact Lens and Anterior Eye. doi: 
10.1016/j.clae.2017.11.003. 
Jacob Cohen (1992) ‘A Power Primer’, Psychological Bulletin. doi: 10.1037/0033-
2909.112.1.155. 
Jansen, M. E. et al. (2010) ‘Effect of contact lens wear and a near task on tear film 
break-up’, Optometry and Vision Science. doi: 10.1097/OPX.0b013e3181d951df. 
Jie, Y. et al. (2009) ‘Prevalence of dry eye among adult Chinese in the Beijing Eye 
Study’, Eye. doi: 10.1038/sj.eye.6703101. 
Jones, L. et al. (2017) ‘TFOS DEWS II Management and Therapy Report’, Ocular 
Surface. doi: 10.1016/j.jtos.2017.05.006. 
Kasctsuwan, N. et al. (1999) ‘Effect of topical ascorbic acid on free radical tissue 
damage and inflammatory cell influx in the cornea after excimer laser corneal 
surgery’, Archives of Ophthalmology. 
Keech, A., Senchyna, M. and Jones, L. (2013) ‘Impact of time between collection and 
collection method on human tear fluid osmolarity’, Current Eye Research. doi: 
10.3109/02713683.2013.763987. 
Kim, J. and Foulks, G. N. (1999) ‘Evaluation of the effect of lissamine green and rose 
bengal on human corneal epithelial cells’, Cornea. doi: 10.1097/00003226-
199905000-00015. 
Knop, E. et al. (2011) ‘The international workshop on meibomian gland dysfunction: 
Report of the subcommittee on anatomy, physiology, and pathophysiology of the 
meibomian gland’, Investigative Ophthalmology and Visual Science. doi: 
10.1167/iovs.10-6997c. 
Kojima, T. et al. (2011) ‘The impact of contact lens wear and visual display terminal 
work on ocular surface and tear functions in office workers’, American Journal of 
Ophthalmology. doi: 10.1016/j.ajo.2011.05.025. 
Korb, D. R. et al. (1994) ‘Tear film lipid layer thickness as a function of blinking’, 
Cornea. doi: 10.1097/00003226-199407000-00012. 
Korb, D. R. et al. (2002) ‘Lid-wiper epitheliopathy and dry-eye symptoms in contact 
lens wearers.’, Cont Lens Anterior Eye. doi: 10.1097/01.ICL.0000029344.37847.5A. 
Korb, D. R. et al. (2005) ‘Lid wiper epitheliopathy and dry eye symptoms’, Eye and 
Contact Lens. doi: 10.1097/01.ICL.0000140910.03095.FA. 
Korb, D. R. et al. (2008) ‘An evaluation of the efficacy of fluorescein, rose bengal, 
lissamine green, and a new dye mixture for ocular surface staining’, Eye and Contact 




Korb, D. R. et al. (2010) ‘Prevalence of lid wiper epitheliopathy in subjects with dry 
eye signs and symptoms’, Cornea. doi: 10.1097/ICO.0b013e3181ba0cb2. 
Labetoulle, M. et al. (2019) ‘Role of corneal nerves in ocular surface homeostasis 
and disease’, Acta Ophthalmologica. doi: 10.1111/aos.13844. 
Lalkhen, A. G. and McCluskey, A. (2008) ‘Clinical tests: Sensitivity and specificity’, 
Continuing Education in Anaesthesia, Critical Care and Pain. doi: 
10.1093/bjaceaccp/mkn041. 
Lemp, A. et al. (2007) ‘The definition and classification of dry eye disease: report of 
the definition and classification of the Dry Eye WorkShop (2007)’, The Ocular 
Surface. doi: 10.1080/09273940701486803. 
Lemp, M. A. et al. (1970) ‘The Precorneal Tear Film: I. Factors in Spreading and 
Maintaining a Continuous Tear Film Over the Corneal Surface’, Archives of 
Ophthalmology. doi: 10.1001/archopht.1970.00990030091017. 
Lemp, M. A. (1995) ‘Report of the National Eye Institute/Industry workshop on Clinical 
Trials in Dry Eyes.’, The CLAO journal : official publication of the Contact Lens 
Association of Ophthalmologists, Inc. 
Lemp, M. A. et al. (2011) ‘Tear osmolarity in the diagnosis and management of dry 
eye disease’, American Journal of Ophthalmology. doi: 10.1016/j.ajo.2010.10.032. 
Lemp, M. A. et al. (2012) ‘Distribution of aqueous-deficient and evaporative dry eye 
in a clinic-based patient cohort: A retrospective study’, Cornea. doi: 
10.1097/ICO.0b013e318225415a. 
López-Miguel, A. et al. (2014) ‘Dry eye exacerbation in patients exposed to 
desiccating stress under controlled environmental conditions’, American Journal of 
Ophthalmology. doi: 10.1016/j.ajo.2014.01.001. 
Lu, P. et al. (2008) ‘Dry eye syndrome in elderly tibetans at high altitude: A population-
based study in China’, Cornea. doi: 10.1097/ICO.0b013e318165b1b7. 
Machado, L. M., Castro, R. S. and Fontes, B. M. (2009) ‘Staining Patterns in Dry Eye 
Syndrome: Rose Bengal Versus Lissamine Green’, Cornea. doi: 
10.1097/ico.0b013e3181930c03. 
Malet, F. et al. (2014) ‘Dry eye disease in French elderly subjects: The Alienor Study’, 
Acta Ophthalmologica. doi: 10.1111/aos.12174. 
Mann, C. J. (2003) ‘Observational research methods. Research design II: cohort, 
cross sectional, and case-control studies’, Emergency Medicine Journal. doi: 
10.1136/emj.20.1.54. 
Manning, F. J., Wehrly, S. R. and Foulks, G. N. (1995) ‘Patient Tolerance and Ocular 
Surface Staining Characteristics of Lissamine Green versus Rose Bengal’, 
Ophthalmology. doi: 10.1016/S0161-6420(95)30769-5. 




Subjective Keeler Tearscope-PlusTM and the Objective Oculus® Keratograph 5M and 
LipiView® Interferometer’, Current Eye Research. doi: 
10.1080/02713683.2017.1393092. 
Martín-Montañez, V. et al. (2016) ‘Effect of environmental conditions on the 
concentration of tear inflammatory mediators during contact lens wear’, in Cornea. 
doi: 10.1097/ICO.0000000000000960. 
McDonald, J. E. (1969) ‘Surface phenomena of the tear film’, American Journal of 
Ophthalmology. doi: 10.1016/0002-9394(69)90008-7. 
Mengher, L. S. et al. (1985) ‘Effect of fluorescein instillation on the pre-corneal tear 
film stability’, Current Eye Research. doi: 10.3109/02713688508999961. 
Miljanović, B. et al. (2007) ‘Impact of Dry Eye Syndrome on Vision-Related Quality of 
Life’, American Journal of Ophthalmology. doi: 10.1016/j.ajo.2006.11.060. 
Mooi, J. K. et al. (2017) ‘Minimising instilled volume reduces the impact of fluorescein 
on clinical measurements of tear film stability’, Contact Lens and Anterior Eye. doi: 
10.1016/j.clae.2017.01.004. 
Moore, J. E. et al. (2009) ‘Concordance between common dry eye diagnostic tests’, 
British Journal of Ophthalmology. doi: 10.1136/bjo.2007.131722. 
Na, K. S. et al. (2015) ‘Depression, stress, quality of life, and dry eye disease in 
korean women: A population-based study’, Cornea. doi: 
10.1097/ICO.0000000000000464. 
Nettune, G. R. and Pflugfelder, S. C. (2010) ‘Post-LASIK tear dysfunction and 
dysesthesia’, Ocular Surface. doi: 10.1016/S1542-0124(12)70224-0. 
Nichols, J. J. et al. (2002) ‘Evaluation of tear film interference patterns and measures 
of tear break-up time’, Optometry and Vision Science. doi: 10.1097/00006324-
200206000-00009. 
Nichols, K. K. et al. (2013) ‘The TFOS International Workshop on Contact Lens 
Discomfort: Report of the definition and classification subcommittee’, Investigative 
Ophthalmology and Visual Science. doi: 10.1167/iovs.13-13074. 
Nichols, K. K., Mitchell, G. L. and Zadnik, K. (2004) ‘The Repeatability of Clinical 
Measurements of Dry Eye’, Cornea. doi: 10.1097/00003226-200404000-00010. 
Norn, M. S. (1969) ‘DESICCATION OF THE PRECORNEAL FILM: I. Corneal 
Wetting‐Time’, Acta Ophthalmologica. doi: 10.1111/j.1755-3768.1969.tb03711.x. 
Novaes, P. et al. (2010) ‘The effects of chronic exposure to traffic derived air pollution 
on the ocular surface’, Environmental Research. doi: 10.1016/j.envres.2010.03.003. 
Offord, D. R. and Kraemer, H. C. (2000) ‘Risk factors and prevention’, Evidence-
Based Mental Health. doi: 10.1136/ebmh.3.3.70. 




combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment 
of dry eye symptoms: Results of a prospective study’, Clinical Ophthalmology. doi: 
10.2147/OPTH.S54658. 
De Paiva, C. S. (2017) ‘Effects of aging in dry eye’, International Ophthalmology 
Clinics. doi: 10.1097/IIO.0000000000000170. 
Patel, S. et al. (1998) ‘The value of a phenol red impregnated thread for differentiating 
between the aqueous and non-aqueous deficient dry eye’, Ophthalmic and 
Physiological Optics. doi: 10.1016/S0275-5408(98)00005-2. 
Patel, S., Plaskow, J. and Ferrier, C. (1993) ‘The influence of vitamins and trace 
element supplements on the stability of the pre‐corneal tear film’, Acta 
Ophthalmologica. doi: 10.1111/j.1755-3768.1993.tb08607.x. 
Paulsen, A. J. et al. (2014) ‘Dry eye in the beaver dam offspring study: Prevalence, 
risk factors, and health-related quality of life’, American Journal of Ophthalmology. 
doi: 10.1016/j.ajo.2013.12.023. 
Peterson, R. C., Wolffsohn, J. S. and Fowler, C. W. (2006) ‘Optimization of Anterior 
Eye Fluorescein Viewing’, American Journal of Ophthalmology. doi: 
10.1016/j.ajo.2006.04.062. 
Portello, J. K., Rosenfield, M. and Chu, C. A. (2013) ‘Blink rate, incomplete blinks and 
computer vision syndrome’, Optometry and Vision Science. doi: 
10.1097/OPX.0b013e31828f09a7. 
Pult, H. et al. (2015) ‘Spontaneous Blinking from a Tribological Viewpoint’, Ocular 
Surface. doi: 10.1016/j.jtos.2014.12.004. 
Pult, H. (2018) ‘Relationships Between Meibomian Gland Loss and Age, Sex, and 
Dry Eye’, Eye & contact lens. doi: 10.1097/ICL.0000000000000467. 
Pult, H. and Riede-Pult, B. (2013) ‘Comparison of subjective grading and objective 
assessment in meibography’, Contact Lens and Anterior Eye. doi: 
10.1016/j.clae.2012.10.074. 
Rege, A. et al. (2013) ‘A clinical study of subtype-based prevalence of dry eye’, 
Journal of Clinical and Diagnostic Research. doi: 10.7860/JCDR/2013/6089.3472. 
Roncone, M., Bartlett, H. and Eperjesi, F. (2010) ‘Essential fatty acids for dry eye: A 
review’, Contact Lens and Anterior Eye. doi: 10.1016/j.clae.2009.11.002. 
Rosenberg, E. S. and Asbell, P. A. (2010) ‘Essential fatty acids in the treatment of 
dry eye’, Ocular Surface. doi: 10.1016/S1542-0124(12)70214-8. 
Savini, G. et al. (2008) ‘The challenge of dry eye diagnosis’, Clinical Ophthalmology. 
doi: 10.2147/OPTH.S1496. 
Schaumberg, D. A. et al. (2009) ‘Prevalence of dry eye disease among US men: 





Schiffman, R. M. et al. (2000) ‘Reliability and validity of the ocular surface disease 
index’, Archives of Ophthalmology. doi: 10.1001/archopht.118.5.615. 
Schirmer, O. (1903) ‘Studien zur Physiologie und Pathologie der Tränenabsonderung 
und Tränenabfuhr’, Albrecht von Græfe’s Archiv für Ophthalmologie. doi: 
10.1007/BF01946264. 
Seen, S. and Tong, L. (2018) ‘Dry eye disease and oxidative stress’, Acta 
Ophthalmologica. doi: 10.1111/aos.13526. 
Senchyna, M. and Wax, M. B. (2008) ‘Quantitative assessment of tear production: A 
review of methods and utility in dry eye drug discovery’, Journal of Ocular Biology, 
Diseases, and Informatics. doi: 10.1007/s12177-008-9006-2. 
Sharma, A. and Hindman, H. B. (2014) ‘Aging: A Predisposition to Dry Eyes’, Journal 
of Ophthalmology. doi: 10.1155/2014/781683. 
Shiraishi, A., Yamaguchi, M. and Ohashi, Y. (2014) ‘Prevalence of upper- and lower-
lid-wiper epitheliopathy in contact lens wearers and non-wearers’, Eye and Contact 
Lens. doi: 10.1097/ICL.0000000000000040. 
Sook Chun, Y. and Park, I. K. (2014) ‘Reliability of 4 clinical grading systems for 
corneal staining’, American Journal of Ophthalmology. doi: 
10.1016/j.ajo.2014.02.012. 
Stapleton, F. et al. (2017) ‘TFOS DEWS II Epidemiology Report’, Ocular Surface. doi: 
10.1016/j.jtos.2017.05.003. 
Sullivan, B. D. et al. (2010) ‘An objective approach to dry eye disease severity’, 
Investigative Ophthalmology and Visual Science. doi: 10.1167/iovs.10-5390. 
Sullivan, B. D. et al. (2012) ‘Clinical utility of objective tests for dry eye disease: 
Variability over time and implications for clinical trials and disease management’, 
Cornea. doi: 10.1097/ICO.0b013e318242fd60. 
Sullivan, D. A. et al. (2017) ‘TFOS DEWS II Sex, Gender, and Hormones Report’, 
Ocular Surface. doi: 10.1016/j.jtos.2017.04.001. 
Szumilas, M. (2010) ‘Explaining odds ratios’, Journal of the Canadian Academy of 
Child and Adolescent Psychiatry. 
Tan, L. L. et al. (2015) ‘Prevalence of and risk factors for symptomatic dry eye disease 
in Singapore’, Clinical and Experimental Optometry. doi: 10.1111/cxo.12210. 
Tesón, M. et al. (2013) ‘Influence of a controlled environment simulating an in-flight 
airplane cabin on dry eye disease’, Investigative Ophthalmology and Visual Science. 
doi: 10.1167/iovs.12-11361. 
Thomas, G. W. et al. (2009) ‘Mechanisms of delayed wound healing by commonly 





Tobaldini, E. et al. (2017) ‘Sleep, sleep deprivation, autonomic nervous system and 
cardiovascular diseases’, Neuroscience and Biobehavioral Reviews. doi: 
10.1016/j.neubiorev.2016.07.004. 
Tomlinson, A. et al. (2006) ‘Tear film osmolarity: Determination of a referent for dry 
eye diagnosis’, Investigative Ophthalmology and Visual Science. doi: 
10.1167/iovs.05-1504. 
Tomlinson, A., Doane, M. G. and McFadyen, A. (2009) ‘Inputs and outputs of the 
lacrimal system: Review of production and evaporative loss’, Ocular Surface. doi: 
10.1016/S1542-0124(12)70186-6. 
Tomlinson, A., McCann, L. C. and Pearce, E. I. (2010) ‘Comparison of human tear 
film osmolarity measured by electrical impedance and freezing point depression 
techniques’, Cornea. doi: 10.1097/ICO.0b013e3181cd9a1d. 
Tong, L. et al. (2010) ‘Impact of symptomatic dry eye on vision-related daily activities: 
The Singapore malay eye study’, Eye. doi: 10.1038/eye.2010.67. 
Tongg, L. et al. (2009) ‘A questionnaire-based assessment of symptoms associated 
with tear film dysfunction and lid margin disease in an Asian population’, Ophthalmic 
Epidemiology. doi: 10.1080/09286580802521317. 
Truong, S. et al. (2014) ‘Sex hormones and the dry eye’, Clinical and Experimental 
Optometry. doi: 10.1111/cxo.12147. 
Tuisku, I. S. et al. (2007) ‘Dry eye and corneal sensitivity after high myopic LASIK’, 
Journal of Refractive Surgery. 
Uchida, A. et al. (2007) ‘Noninvasive Interference Tear Meniscometry in Dry Eye 
Patients With Sjögren Syndrome’, American Journal of Ophthalmology. doi: 
10.1016/j.ajo.2007.04.006. 
Uchino, M. et al. (2008) ‘Japan Ministry of Health Study on Prevalence of Dry Eye 
Disease Among Japanese High School Students’, American Journal of 
Ophthalmology. doi: 10.1016/j.ajo.2008.06.030. 
Uchino, M. et al. (2011) ‘Prevalence and risk factors of dry eye disease in Japan: 
Koumi study’, Ophthalmology. doi: 10.1016/j.ophtha.2011.05.029. 
Uchino, M. and Schaumberg, D. A. (2013) ‘Dry Eye Disease: Impact on Quality of 
Life and Vision’, Current Ophthalmology Reports. doi: 10.1007/s40135-013-0009-1. 
Um, S. B. et al. (2014) ‘Spatial epidemiology of dry eye disease: Findings from South 
Korea’, International Journal of Health Geographics. doi: 10.1186/1476-072X-13-31. 
Varikooty, J. et al. (2015) ‘Variations in observable lid wiper epitheliopathy (LWE) 
staining patterns in wearers of silicone hydrogel lenses’, Contact Lens and Anterior 
Eye. doi: 10.1016/j.clae.2015.05.004. 
Varikooty, J. and Simpson, T. L. (2009) ‘The interblink interval I: The relationship 




and Visual Science. doi: 10.1167/iovs.08-1843. 
Vehof, J. et al. (2014) ‘Prevalence and risk factors of dry eye disease in a british 
female cohort’, British Journal of Ophthalmology. doi: 10.1136/bjophthalmol-2014-
305201. 
Viso, E., Rodriguez-Ares, M. T. and Gude, F. (2009) ‘Prevalence of and associated 
factors for dry eye in a Spanish adult population (The Salnes Eye Study)’, Ophthalmic 
Epidemiology. doi: 10.1080/09286580802228509. 
Ward, S. K. et al. (2010) ‘Passive cigarette smoke exposure and soft contact lens 
wear’, Optometry and Vision Science. doi: 10.1097/OPX.0b013e3181d95188. 
Whitcher, J. P. et al. (2010) ‘A Simplified Quantitative Method for Assessing 
Keratoconjunctivitis Sicca From the Sjögren’s Syndrome International Registry’, 
American Journal of Ophthalmology. doi: 10.1016/j.ajo.2009.09.013. 
Willcox, M. D. P. et al. (2017) ‘TFOS DEWS II Tear Film Report’, Ocular Surface. doi: 
10.1016/j.jtos.2017.03.006. 
Wojtowicz, J. C. and McCulley, J. P. (2009) ‘Assessment and impact of the time of 
day on aqueous tear evaporation in normal subjects’, Eye and Contact Lens. doi: 
10.1097/ICL.0b013e31819c2963. 
Wolff, E. (1946) ‘The muco-cutaneous junction of the lid margin and the distribution 
of the tear fluid’, Transactions of the Ophthalmological Societies of the United 
Kingdom, 66, pp. 291–308. 
Wolffsohn, J. S. et al. (2017) ‘TFOS DEWS II Diagnostic Methodology report’, The 
Ocular Surface. doi: 10.1016/j.jtos.2017.05.001. 
Wolffsohn, J. S. et al. (2018) ‘Blink Test enhances ability to screen for dry eye 
disease’, Contact Lens and Anterior Eye. doi: 10.1016/j.clae.2018.06.003. 
Wolkoff, P. et al. (2005) ‘Eye complaints in the office environment: Precorneal tear 
film integrity influenced by eye blinking efficiency’, Occupational and Environmental 
Medicine. doi: 10.1136/oem.2004.016030. 
Yeniad, B., Beginoglu, M. and Bilgin, L. K. (2010) ‘Lid-wiper epitheliopathy in contact 
lens users and patients with dry eye’, Eye and Contact Lens. doi: 
10.1097/ICL.0b013e3181d94e82. 
You, Y. S., Qu, N. Bin and Yu, X. N. (2016) ‘Alcohol consumption and dry eye 
syndrome: A meta-analysis’, International Journal of Ophthalmology. doi: 
10.18240/ijo.2016.10.20. 
Zhang, J. et al. (2017) ‘A link between tear breakup and symptoms of ocular irritation’, 
Ocular Surface. doi: 10.1016/j.jtos.2017.03.001. 
Zhang, Y., Chen, H. and Wu, X. (2012) ‘Prevalence and risk factors associated with 
dry eye syndrome among senior high school students in a county of shandong 
province, China’, Ophthalmic Epidemiology. doi: 10.3109/09286586.2012.670742. 
